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                                      INTRODUCTION 
 
 
            Bladder cancer accounts for 7% of all cancers in male and 2% of all 
cancers in female.  Urinary cytology has prominent role in the multidisciplinary 
diagnostic  approach to bladder cancer. It is used as a valuable adjunct to 
cystoscopy and biopsy for diagnosis and follow up of patients with bladder 
cancer 
           Urine cytology remains gold standard for bladder cancer screening. It is 
the test against which all others are compared when evaluating potential bladder 
tumor markers. It has excellent specificity with few false positive cases 
         Cytological examination of voided urine is a non-invasive screening test 
for bladder tumors, which can be carried out in remote areas of the country. By 
cytology one can even classify type and grade malignancy. 
         In 1945 Papaniculoau and Marshall recommended cytological 
examination of urinary sediment for diagnosis and follow up of patients with 
urological malignancies. The prognostic value of conventional cytology to 
monitor patients with superficial bladder carcinoma is well established. While 
cystoscopy and biopsy are optimum for diagnosis of visible disease,  entire 
bladder mucosa can be sampled by cytology, enabling detection of   occult  
urothelial abnormalities.  
       Traditionally cytological examinations have been used to detect in situ and 
early invasive bladder cancer in high-risk population and in conjunction with 
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cystoscopy and biopsy to diagnose new or recurrent bladder tumor. Cytology 
also has been used to identify persistent tumor after transurethral resection. 
         Urine Cytological examination  is a simple, safe, and inexpensive method  
to detect hidden urothelial tumours. Urinary tract  tumours are often multifocal. 
Indications for urine cytology examinations are 1) detection and diagnosis of 
tumours, carcinoma in situ, inaccessible lesions  in ureters, pelvis, diverticuli,  
2) Screening of high risk patients 
( chemical or metal exposure, smokers)  3) Monitor tumours and therapy 
         Cystoscopy remains the standard for the diagnosis and surveillance of 
bladder tumors, allowing the lesions to be mapped and sampled. However, 
cystoscopy cannot explore  whole bladder urothelium, and cannot diagnose all 
carcinoma in situ cases or lesions of upper urinary tract. Thus, it must be 
combined with urinary cytology, particularly in search for tumor cells from 
high-grade lesions, wherever their location in the urinary tract. 
         Urine cytology can detect bladder tumor before it can be detected 
cystoscopically. Urine cytology is still indispensable in the management of 
patients with transitional cell carcinoma. It remains as a gold standard for 
bladder cancer screening. All Ultrasound detected bladder neoplasm will be 
screened by urine cytology collected randomly. Urine cytology will be 
corroborated with histopathological examinations 
 
 
  
 
 
 
 
 
 
 
 
AIM  OF  THE  STUDY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 
 
 
 
AIMS   OF  THE  STUDY 
 
1. To Correlate Urine cytology with Histopathology of  the  Bladder   
Transitional  Cell Carcinoma. 
 
 
2. To Study the Role of Urinary Cytology in the diagnosis of  Bladder 
Transitional  Cell  Carcinoma. 
 
 
3. To Find out the Correlation between the Grading by Urine cytology  and 
Histopathology. 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
REVIEW  OF                                                  
LITERATURE 
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REVIEW  OF LITERATURE 
         Bladder  cancer  is  three times more common in male than female and 
twice as common among whites  compared to blacks. Bladder cancer  was first  
noted  in man worked in aniline dye industry in 1895. Common age group is 65 
to 70 years old.  Most of patients are older than 50 years of age 
           The bladder stores temporarily concentrated toxic products of renal 
excretion and is exposure to environmental carcinogens. Aniline  dyes 
containing arylamines, e.g.benzidine, beta naphthylamine are most important 
risk factors for the development of transitional cell carcinoma. High-risk 
occupations include chemical, dye, textile, rubber, and plastic workers as well 
as painters and hairdressers. Cigarette smoking is one of risk factor for bladder 
cancer. Certain drugs [eg.chemotherapeutic agents, phenacetin and opiates] are 
highly associated with the development of bladder cancer. 
          Schistosoma haematobium infection is a risk factor for sqamous cell 
carcinoma. Previous Radiation exposure of the bladder  increases the risk of 
urothelial carcinoma. Certain  genetic alterations are observed in urothelial cell 
carcinoma, comman are chromosome 9 monosomy or deletions of 9p and 9q, 
deletions of 17p, 13q, 11p and 14q.  
                    The Genetic pathway, which is initiated by deletions of tumor 
suppressor genes on 9p and 9q leads to superficial papillary tumors, a few of 
which may then acquire P53 mutations and progress to muscle invasion. 
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Initiation  by P53 mutation,  second pathway, which  leads to carcinoma in situ 
and with loss of chromosome 9, progresses to invasion. 
           The urocarcinogens, by injuring the coding units of the urothelial cells, 
render them defective, leading to hyperplasia and neoplasia, with the action of 
promoters. 
TUMORS OF THE URINARY BLADDER17 
 
Benign epithelial tumors 
 
Typical papilloma 
Inverted papilloma 
Villous adenoma 
Mucinous cystadenoma of the urachus 
Squamous papilloma 
Malignant epithelial tumors 
 
Transitional cell carcinoma 
Papillary 
(1) Superficial 
(2) Muscle - invasive 
Non-papillary 
(1) Transitional cell carcinoma in-situ 
(2) Invasive transitional cell carcinoma 
Squamous cell carcinoma. 
Adenocarcinoma 
6 
 
Carcinomas of more than one histologic type 
Mesenchymal tumors 
 
Benign 
Malignant 
(1) Leiomyosarcoma 
(2) Rhabdomyosarcoma 
(3) Others 
Mixed tumors 
Adenofibromas and adenosarcomas 
Carcinosarcoma 
Hematopoietic neoplasms 
Lymphoma 
Leukemia 
Plasmacytoma 
Miscellaneous primary tumors 
Paraganglioma 
Carcinoid 
Malignant melanoma 
Dermoid cyst 
Yolk sac tumor . 
Metastatic tumors 
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URINE CYTOLOGY 
 
           Tumor cells in the urine were noticed  first by Sanders in 1864 and 
Dickson in 1869. In 1892, Ferguson suggested that microscopic examination of 
the urine sediment, except for cystoscopy was the best method for diagnosing 
tumors of the bladder. In 1895, Rovising reported malignant cells in the urine 
sediment of 3 out of 7 patients with kidney tumors. 
         In  1928, Zemansky correlated urinary findings with subsequent tissue 
examination in 46 cases of suspected tumors and reported  urine unfit for 
cytologic study. Cytologic diagnosis Interest is  waned until the studies by 
Papanicolaou and Marshell in 1945, supplemented by Papanicolaou a year later, 
he  demonstrated the usefulness of smear technique in diagnosing cancers of 
urinary organs. They  considered urine sediment most suitable for the 
identification of cells with malignant characteristics, Because of the normal 
desquamation from epithelial  surfaces, which increases in the presence of 
neoplasia32.  
            In 1945, Papanicolaou and Marshall demonstrated that a bladder tumor 
undergoes exfoliation, which renders possible its recognition by detection of 
abnormal cells in the urine, cytology has become an important adjuvant for the 
diagnosis and follow up of patients with cancer. Umiker et al, In 1964 reviewed 
the literature on the role of urinary cytology and found  positive results ranging 
from 26.1 to 100% with an average of 71.6%. In 1972, Harris and associates 
performed bladder irrigation, his yield improved by 30% over urinary cytology. 
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In 1970, Esposti and associates recognised  the importance of the pathological 
grading of the tumour in influencing the cytological results43. 
 
            Tumours of the urinary tract are relatively inaccessible to direct biopsy 
and the tumours are often multifocal. Since the entire mucosal surface is bathed 
in urine, in theory urine is the perfect specimen to examine for evidence of 
tumor in the urinary tract. 
Urinary cytology is useful in the detection of 
1. Carcinoma in situ. 
2. Urothelial carcinoma in its preclinical phase 
3. Follow up of patients after treatment to detect any residual or recurrent 
tumours. 
           Cytologic examination of the sediment of voided urine is the  
noninvasive method of  detection, diagnosis and follow up of tumours of the 
bladder, upper tract  and other anatomic components of the lower urinary tract. 
Urine cytology is a cost effective method. 
               Urine cytology remains gold standard for bladder cancer screening. 
Urine cytology  is the test against which all others are compared when 
evaluating potential bladder tumor markers. It has excellent specificity with few 
false positive cases. High  grade malignant cells are  detected  by  urine 
cytology, even before a  cystoscopically  distinguishable gross lesion. It’s 
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capable of detecting malignant non-exophytic tumour types than that ultrasound 
cannot detect34. 
        In  1980,  study conducted by M. N. EL-Bolkainy  showed that the 
cytology is highly effective in the primary diagnosis of high grade transitional 
cell carcinoma with a positive rate of 93-94.7%. 
         The study conducted by Leopold G. Koss et al 1985 also showed  that  for 
diagnosis of high grade tumours, cytology of voided urine is highly reliable in 
the with a sensitivity of 94.2%. The  sensitivity was about 100%  in  primary 
flat carcinoma in situ  
           In Patients with low-grade non-invasive tumours can be followed up 
cytologically. Patients with high-grade cytological abnormalities predict an 
aggressive tumour course , increase  risk  of  recurrence, while negative 
cytological findings have a very low risk of recurrence. 
            The study  conducted by Niels Harving et al 1988 , concluded that 
urinary cytology is also better indicator of the presence of concomitant 
urothelial atypia than preselected mucosal biopsies. 
          Post operative (radical operation) examination of urine  cytology  for 
malignant cells should be monitored for  development of new tumors in the 
kidney ureter or occasionally in the intestine itself. 
         Clinical history is important & imperative for the elimination of 
misdiagnosis. Pertinent information includes the method of specimen collection, 
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the presence of calculi and past therapies. To use urine cytology most 
effectively it is important first to understand its advantages and limitations. 
 
Advantages of voided urine cytology. 
1. Simple, can be easily collected. 
2. Repeated if necessary, with little or no inconvenience for the patient. 
3. Inexpensive. 
4. Non invasive. 
5. Can be done even in remote areas of the country. 
6. Detects high grade malignancy before cystoscopy can detect. 
7. Samples of urine may contain representative cells from the entire urinary 
    tract. So that the entire system can be surveyed. 
Disadvantages of voided urine cytology 
1. Low cellularity. 
2. Contamination from female genital tract. 
3. Not localizes the tumor 
4. May contain degenerated cells or reactive transitional cells which may give 
false positive results.    
           An important diagnostic principle is that  higher the grade of the tumor, 
the more accurate the diagnosis. For  diagnostic inaccuracy,  there are several 
reasons. Urine is an inhospitable environment for cells. So degenerative changes 
that make diagnosis difficult are common. 
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          False positive results can occur due to misreading  of atypical cellular 
changes as malignant. Common causes of cellular atypia are cystitis, senile 
prostate, calculi, chemotherapy and radiotherapy effects, and virus infection. 
            Positive  urine cytologic diagnosis should always be confirmed 
histologically,  before definitive therapy is  instituted,  because False positive 
diagnosis of bladder cancer may lead to radical therapy37. Most patients with 
false positive cytological findings may develop a tumor in subsequent years and 
therefore need repeated examinations of urine for malignant cells  
              False negative diagnosis may be of more important clinical 
consequence. In diagnosis of  papilloma and well differentiated transitional cell 
carcinoma, cytology can be difficult or impossible  because the cells are nearly 
normal appearing. False negative diagnosis mainly  due to low cellularity, poor 
preservation or obscuring of malignant cells by inflammatory cells. 
Suboptimal Specimen 
         According to Sheldon Bastacky et a41 1999, suboptimal  urinary specimen 
is considered, if the specimen had one or more of the following deficiencies 
1. Less than 15 intermediate or basal urothelial cells. 
2. Obscuring of malignant cells by red blood cells or inflammatory cells. 
3. Poor cellular preservation. 
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Following newer diagnostic techniques have been studied to increase diagnostic 
efficacy. 
 Flow cytometry39. 
 Image analysis. 
 Assay of Nuclear matrix protein 22 (NMP22)40  
 Immune histochemical analysis of p53 over expression21. 
 Immunology e.g.-blood group isoantigens and monoclonal antibodies to  
a variety of tumor associated antigens40. 
 Telomerase  activity40  
 Aura  Tek FDP assay (Fibrin/Fibrinogen Degradation products). 
 Detecting hyaluronic acid/ Hyaluronidase levels11.     
BASIC SPECIMEN 
         There are three basic types of exfoliated urinary tract specimens: 
(1) Voided urine 
(2) Catheterized urine, and 
(3) Brushing/washing specimens 
 
         "Clean catch" voided urine is recommended for screening purposes. 
However, in  some  cases bladder washing may be the method of choice in 
which there is a high clinical suspicion for bladder malignancy. 
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         Specimens should be processed immediately or refrigerated and processed 
as soon as possible. Immediate  fixation with 50% ethanol may preserve the 
specimen for several days,  If a delay is anticipated30,51. 
         A solution of 25% ethanol [equal volume of 50% ethanol and urine.] is 
widely used. This recommended percentage is in order to lessen the shrinkage 
and hardening effects of more  concentrated solution52. 
        All urine cytology specimens are dilute sufficiently as to require some 
form of cell concentration. Initially, cytologic findings were assesed on smears 
made from the sediment of centrifuged specimen. Subsequently developed 
methods include thin membrane filtration, cytocentrifugation and most recently 
mono layer technique11. 
        Urinary samples can be processed by the several techniques including 
direct smears, membrane filters and cytocentrifugation. Every techniques has  
certain advantages and disadvantages. In general direct smears are easiest to 
prepare, but suffer from suboptimal display of cellular details and high cell loss. 
Membrane filters techniques  produce the best cytologic details, but are difficult 
to prepare51. 
         Cytocentrifugation and Cytyc thinprep liquid based cytology are 
appropriate methods for cytology based molecular studies but 
cytocentrifugation is the quality standard for current treatment of urinary 
samples because of its lower cost9. 
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         Papanicolaou stain is most usually preferred. Since fine nuclear detail is 
often crucial to proper diagnosis. 
 
Voided Urine 
            Normal voided urine usually contains only a few cells. Normal urine 
contains approximately 10 cells/ml51. Voided urine also contains significant 
amount of vaginal and skin contamination particularly in female. Increased 
cellularity may be seen with instrumentation, stones or neoplasms. 
           The transitional cells in urine usually have a trapezoidal (truncated 
pyramid or trapezium) shape. The transitional cells in a voided urine specimen 
are relatively uniform. However, cells can be  vary from parabasal to relatively 
large. The nuclei are  vary  from   round to oval with smooth nuclear 
membranes. The chromatin is either  delicate or condensed. Small nucleoli may 
be seen. There is usually contain a moderate amount of cytoplasm37. 
           Urine cytology should be performed on freshly voided urine .  The most 
useful  sample is  mid morning sample. Fractionated cytology usually did not 
improve the diagnostic accuracy of urinary cytology and that any part of voided 
stream is adequate for cytological purposes22. Samples must  be collected in a 
clean container and immediately sent to the laboratory. If the specimen has to be 
transported or kept overnight to preserve the cells  alcohol should be added  
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           By using adhesive fluids Cell loss from slides can be minimized. The 
paraffin blocks of sediments are useful in identification of papillary tumor 
fragments in  the  specimen. 
        There  must be three optimum number of voided urine samples to submit. 
Of the neoplasms that can be diagnosed with voided urine cytology, about 80% 
will be on the first specimen, 15% on the second, and the rest on the third34. 
         Degenerative changes, are common in voided urine specimens. Factors 
causing degeneration include variable osmolality of the urine and high acidity. 
Degeneration of urothelial cells begin prior to exfoliation and continuous while 
the cells are in contact with urine prior to and after voiding. 
         Specimen should not be submitted from first morning voiding, 24 hours 
collection or drainage bags because prolonged exposure of urothelial cells to 
urine causes degenerative changes. 
Catheterized urine 
          Simple catheterization usually increases the cellularity over voided urine 
specimens, and specimen may be somewhat better preserved. However, it 
makes the diagnosis of low-grade lesions more difficult because pseudo 
papillary clusters may be present, and lesions in the urethra may be missed. 
Bladder wash 
          Bladder wash specimens are superiorly  diagnostic to voided urine 
specimens. Has better preservation of specimen, more cellular and there is less 
contamination  of the background than voided urine specimen. It is important 
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that the urologist submit both the urine present in the bladder and the saline 
wash at cystoscopy ("cysto urine"). Cysto urine usually  does pick up a 
significant number of additional cases of cancer. 
        To detect lesions in the urethra, freshly voided urine specimen should be 
submitted.   Although bladder washing is superior to voided urine in diagnosis, 
it is inconvenient, relatively expensive,  uncomfortable, and has a risk of 
infection. 
 
Advantages and Disadvantages of Voided Urine and Bladder Washing 
Specimen. 
  
 
Advantages Disadvantages 
Voided urine 
Easy to obtain specimen 
Good sensitivity for high- grade 
tumor 
Sample entire tract 
Degeneration 
Few cells, particularly in lowgrade 
tumor 
Contamination, especially from 
female genital tract 
Bladder washing 
    Excellent preservation 
    High sensitivity,  
    Almost no contamination 
Inconvenient, uncomfortable, expensive 
Possible risk of infection, spread of 
tumor 
Limited sample 
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UROTHELIAL CELLS 
            Urothelium is composed of superficial layer of large cells which cover 
several layers of uniform smaller cells like an umbrella, hence named umbrella 
cells. Superficial cells have abundant cytoplasm and typical and convex, 
concave surfaces with multiple nucleoli. They have a rigid surface membrane 
which does not round up in fluid environment. So that these  superficial cell 
elements are readily identified in urinary samples. It produce and secrete small 
amount of mucin. 
            Reactive superficial cell may look like a high grade neoplastic cell but 
truly malignant cells rarely if ever differentiate towards superficial cells. So 
these cells should not be misinterpreted as neoplastic cells .  when N; C ratio 
(Nuclear; Cytoplasmic) of 1: 2 or less should be considered malignant. 
            Sub superficial transitional cells lie beneath the superficial cell layer. 
They are uniform,  smaller, normally filled with glycogen which washes out 
during processing leaving a cleared cytoplasm, surrounding an ovoid nucleus. 
These cells are  arranged in 3 to 4 cell thick layers but probably not exceeding 
6. They are inactive, replicate every 200 to 500 days. In  urinary specimen, 
these cells tend to cluster . Instrumentation can produce papillary aggregates in 
urine as  false  positive,  but these aggregates are having smooth borders and 
cells are uniform. Papillary configuration per se is an unreliable feature of 
neoplasia. Reactive sub superficial transitional cells develop nuclear 
enlargement, cytoplasmic  vacuolation, and prominent nucleoli51.  
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         Most neoplastic cells tend to be differentiate toward subsuperficial 
urothelial cells .It is these elements to which comparison of nuclear 
characteristics between neoplasia and normal are made. 
        Cytoplasmic vacuolization and prominent nucleoli can be seen in either 
reactive transitional cells or in high grade transitional cell carcinoma, but their 
presence excludes low grade transitional cell carcinoma. 
 
Degenerated Transitional Cells 
       Degeneration caused by inflammation, stones, trauma, etc can result in 
bizarre transitional cells contain  darkly condensed coarse or pyknotic 
chromatin Although,chromatin of these benign cells is usually smudged or 
degenerated such changes can resemble cancer. In contrast, the chromatin 
granules of cancerous cells are characteristically crisp and well preserved. In  
degenerated transitional cells , Margination of the chromatin, with central 
clearing, is also frequent. Degenerated nuclei may further undergo karyolysis 
and karyorrhexis and become washed out or broken up. The cytoplasm may 
disintegrate and be merely a tag attached to the nucleus (comet cell) or absent 
together37 
Significance of Papillary Clusters. 
           Papillary  aggregates produced by Instrumentation, catheterization or 
even simple manipulation of the bladder, that mimic tissue fragments detached 
from low grade papillary tumors. 
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             The papillae from transitional cell carcinoma tend to be crowded and 
disorganized, with irregular borders and mild nuclear atypia, while post 
instrumentation pseudo-papillae tend to be ball-shaped, cohesive, or papillary 
clusters with smooth borders outlined by a densely staining cytoplasmic collar. 
However, when papillary clusters are shed in urine in low grade transitional cell 
carcinoma, they may be confused  with  artifacts induced by instrumentation45. 
       Uniform central nuclei, smooth nuclear membranes, fine even chromatin, 
cytoplasmic vacuoles, low N/C ratios and general lack of crowding favor a 
benign diagnosis16. 
Squamous Cells and Squamous Metaplasia 
         Squamous cells are also  common finding in urine specimens. Source of 
squamous cells are contamination of urine by squamous cells from urethral 
meatus, female genital tract, cells from trigone, metaplastic squamous cells. 
              In  chronic inflammation or irritation (stones, indwelling catheter), 
Squamous metaplasia occurs The metaplastic cells are usually intermediate, 
mature, or superficial squamous cells. Squamous metaplasia should be 
diagnosed only after exclusion of contamination, thus usually it requires a 
catheterized specimen. 
Columnar cells 
        Columnar cells generally account for less than 5% of all cells in a urinary 
specimen. They commonly appear after prostatic surgery or instrumentation75. 
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Red blood cells and inflammatory cells 
            Normally the urine is  usually free of inflammatory cells and RBCs. 
Significant numbers indicate disease or trauma and when abundant may obscure 
the presence of tumor cells.  Hematuria results from any disease or trauma to 
the Kidney and/or urinary tract and is seen with calculi, neoplasm, infections 
 
 
Cellular Reaction to Therapeutic Agents 
       1. Cyclophosphamide is a alkylating agent given systemically and 
metabolized to active form. The active form is mostly concentrated in urine and 
remains in contact with urothelial cells for relatively prolonged periods until 
voided. Cyclophosphamide causes cellular atypia it closely mimic cancer. The 
presence of multinucleated cells with signs of nuclear degeneration 
(karyorrhexis, lysis, and nuclear vacuolization) suggests chemotherapy effect. 
       2. Alkylated  agents like  Mitomycin C and Thiotepa are topically applied 
administrated in their active form for prevention or treatment of bladder 
neoplasm. The drugs remain in contact with urothelium for limited periods prior 
to voiding. Their cytologic manifestations are confined almost exclusively to 
superficial cells, where they cause enlargement of both cytoplasm and nuclei 
resulting in characteristic but bizarre cells. Nuclei are usually not 
hyperchromatic but those that are usually have smudgy appearing chromatin. 
Multiple small nucleoli are common. The cytoplasm is degenerated, vacuolated 
and frayed. 
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      3. Bacillus Calmette-Guérin [BCG] vaccine is an increasingly common 
therapeutic agent for bladder cancer that is particularly effective in treating 
carcinoma in situ. BCG therapy can also cause epithelial atypia, including slight 
nuclear hyperchromasia with cytoplasmic basophilia. In contrast with cancer, 
the N/C ratio is preserved and the nuclear membranes are smooth. Significant 
nuclear pleomorphism, prominent nucleoli, or cytomegaly are not seen in the 
transitional cells. 
 
Radiation 
        Radiation can cause certain cytologic changes, especially multinucleation, 
cytoplasmic vacuolization and nuclear pyknosis. Bizarre nuclear abnormalities 
can occur51. 
        It is not possible to distinguish with any degree of certainity malignant 
from non-malignant  irradiated urothelial cells in urine. History of previous 
irradiation should be given to the cytologist.If numerous bizarre cells appear 
long after radiation, or if there has been an interim period when cytologic 
appearances were normal, then recurrence is strongly suggested36.            
  The interpretation of urine  cytology  were  classifieds  as 
Negative :   Normal  transtitional  cells 
Atypia :      Atypical  cells  in loose  clusters  with  slightly  increased  nuclear  
                    cytoplasmic  ratio  with  fine  chromatin  and  small  nucleoli 
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Suspcious: Cells  with  abnormal  features  short definite diagnosis of  
malignancy 
Positive: Loose  clusters  or  isolated  cells  with  increased   nuclear  
cytoplasmic  ratio with fine to coarse chromatin  and  prominent  nucleoli 
 
           For this purpose of study cytological negative, atypical/ reactive and 
degenerated smears are combined into one group i.e. cytologic negative. 
Suspicious and positive smears  were combined into another group i.e. cytologic 
positive. 
Papanicoloau staining  
Staining Technique 
1. Fix smears (while still moist) in equal parts of alcohol and ether for 15 - 
30 minutes. 
2. Rinse smears in distilled water. 
3. Stain in Harri’s Haematoxylin for 4 mts. 
4. Wash in tap water for1-2mts. 
5. Differentiate in acid alcohol. 
6. Blue in tap water or 1.5%sodium bicarbonate 
7. Rinse in distilled water. 
8. Transfer to70% then 95% alcohol for few seconds. 
9. Stain in OG-6 for 1-2 mts 
10.Rinse in 3 changes of 95% alcohol for few seconds each. 
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11. Stain in EA-36 for 1 - 2 mts 
      12. Rinse in 3 changes of 95% alcohol for few seconds each 
      13. Dehydrate in absolute alcohol, clear in xyol and mount in   
DPX.[Distrene   Dibutylphthalate Xlol] 
Result 
Nuclei - Blue 
Acidophilic cells - Red to Orange 
Basophilic cells - Green to blue green 
Cells or fragments of tissue penetrated by blood- Orange to Orange Green 
Criteria for cytological diagnosis 
Atypical/reactive cells 
       Enlarged cells with vacuolated cytoplasm and large centrally placed nuclei 
with smooth  nuclear borders and multiple prominent nucleoli and fine even 
chromatin were diagnosed as atypical/reactive cells 
Degenerated cells 
      Cells with disintegrated cytoplasm, smudged or degenerated chromatin and 
degenerated  nuclei were diagnosed as degenerated cells. 
Suspicious cells 
       The diagnosis of suspicious was rendered when the evidence was judged to 
be strongly  suggestive of cancer but insufficient for an outright- diagnosis. 
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H & E staining [Heamatoxylin and Eosin] for tissue sections 
Staining technique 
1. Dewax sections, hydrate, through graded alcohol to water 
2. Remove fixation pigments if necessary. 
3. Stain in alum hematoxylin of choice for a suitable time. 
4. Wash well in running tap water until sections ‘blue’ for 5 minutes or 
less. 
5. Differentiate in 1% acid alcohol (1% Hcl in 70% alcohol) for 5- 10 sec 
6. Wash well in tap water until sections are again blue (10 - 15 minutes) or 
7. Blue by dipping in an alkaline solution (eg ammonia water) followed by 
a 5 min tap water wash. 
8. Stain in 1% eosin for 10 minutes 
9. Wash in running tap water for 1 - 5 minutes 
10.Dehydrate through alcohols, clear and mount. 
Results 
Nuclei - blue/black 
Cytoplasm - varying shades of pink 
Muscle fibres - Deep pink/red 
RBC[Red blood Cells] -Orange/red 
Fibrin - deep pink 
For heamatoxylin and eosin staining of cytology smears 0.5% acid alcohol 
is used  for differentiation 
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Histopathology slides were diagnosed as 
No malignancy 
Low grade transitional cell carcinoma 
High grade transitional cell carcinoma 
  Then Cyto - Histological correlation was done. 
           Correlation was also done with cystoscopic findings and cytological, 
histopathalogical findings. Histological diagnosis was based on WHO grading. 
The tumors showing delicate orderly arranged papillary structures with minimal 
crowding,  with enlarged cells, round to oval slightly variable sized nuclei, 
inconspicuous nucleoli and occasionally found mitosis were classified as low 
grade transitional cell carcinoma. The tumors showing disorderly arranged 
papillary structures with loss of polarity, enlarged cells with pleomorphic nuclei 
showing multiple prominent nucleoli and frequent mitosis were diagnosed as 
high grade transitional cell carcinoma. 
 
Low-grade transitional cell carcinoma 
        Papillary or loose clusters of large cells with homogeneous cytoplasm and 
eccentricity placed enlarged nuclei with irregular nuclear borders, fine even 
chromatin were diagnosed as low grade transitional cell carcinoma . 
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High-grade transitional cell carcinoma 
         Loose clusters or isolated large cells with vacuolated cytoplasm, 
eccentricity placed  pleomeorphic nuclei with increased N/C ratio [Nuclear 
Cytoplasmic ratio], irregular nuclear  borders, coarse uneven chromatin and 
multiple nucleoli were diagnosed as high grade transitional cell carcinoma. 
Cyto-hystological correlation was done patient based rather than specimen 
based. Such that one patient with multiple specimens, correlation was tabulated 
only one time. 
A positive correlation satisfied one of the two conditions. 
1. A patient with at least one positive urinary cytology concurrent with 
positive histological specimen or 
2. A patient with consistently negative urinary cytology and histology 
specimen. 
A discordant correlation was taken when at least one positive diagnosis 
by either cytology or histology and negative findings by the other modality. 
An explanation of discordant results was determined 
         Urine  cytology  is  a diagnostic  tool  in  detection  and  follow  up  of  
bladder  carcinoma. Its  reliability   has  been  reduced  by   relative  
inexperience  of  pathologists,  by lack  of  cellular criteria regarding  
morphology of  low  grade  papillary  and  flat  lesions  of  bladder.  Overall ,   
cytohistologic   correlation  for  patients  with bladder cancer  was 92%.   
Positive  cytology  occur in  63% of  patients with  grade I  transitional  cell  
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carcinoma,   suspicious  for  malignancy  in 14%. Dyplastic  cells in cytology   
may  represent   under  interpretation  of  low  grade papillary  bladder   tumour.   
The  cells of low  grade  TCC  and dyplasia,  differ  morphologically both  from  
normal   and  reactive  elements,  can  be  detected in  cytology  specimens.     
These  changes  are  often  subtle  and  require  experience for  interpretation. 
              Urinary  cytology  was  performed   on  260  cases of  histologically   
proven  urothelial  cancer  by  curling.  The size,  site,  shape and  histological  
grade  of  tumour  was  recorded,  and  classifieds   by  TNM  Staging.  Overall, 
urine  cytology  was  positive in  135,   suspicious  in  28  and  negative  in 97  
cases.  Malignant  urothelial  tumours  were  large  papillary  and  solid,  
moderately  or  poorly  differentiated   and  invasive  T2-4.  Most  of the upper   
tract  tumours  had  positive  urinary  cytology.   The  study  confirms  
exfoliative  urinary  cytology  is  useful   in   detect  malignant  bladder  tumours 
including  carcinoma in  situ  and  others  tumours in  less  accessible parts  of  
urinary  tract. 
          Another   study  comparing  abdominal  ultrasound  and  cystoscopy  was   
carried out   in  187  patients  by neils  Juul et al.  20  bladder  tumours  sized  
from  2  to  5mm  were   overlooked  in  cytology.  Combination of  cytoscopy  
with urine  cytology  increased  diagnostic  sensitivity.  To  reduce  cost  
effectiveness  and  patient  inconvience  in  bladder  both  ultrasound  and  urine  
cytology  is  alternative  to  cystoscopy,  but  only  in  low  risk  bladder  
tumour. 
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             O” Donoghue  et al (1991),  have  analysed  accuracy  of  cytological  
examination  in  voided  urine  in  a population  of  265  patients   presented  
with  suspected  bladder  tumours.   Bladder  tumours   was  confirmed by  
tissue  histologically  in  51  patients.  Of  these  42  patients  were  identified  
by  cytology  examination.  Overall   34  patients   are  labelled  as  malignant 
on  cytology,  of  which 2   are  negative  on  final  histology.   13  patients are  
labelled  as  suspicious,  but  3  cases  are  benign on  histological  diagnosis. 
These  data give  sensitivity of  urine  cytology  in  diagnosing  bladder  cancer 
of  82%,  specificity of 97%,  positive  predictive  value  of  94%  and  negative  
predictive  value of  96%. 
            Ro  J Y et al, he  compared  the  cytological  and  histological features of 
superficial bladder  cancer.  Despite  technologic  advances  in  diagnostic  
skills,  cytological  histological  evaluation  still  standard  for  the identification  
of  bladder  cancer,  treatment  selection and  post  treatment  survillence. The 
appropriate  collection  and  handling of  sample  is  the key  to proper  
interpretation of  cytological  specimens. Depend upon  the  different histology 
of tumour,  treatment  differs. So   both  urologists  and  pathologists  must 
known  about importance  of muscularis  mucosa, TCC  may invade  this  layers  
without  extending  into  true  muscle 
        Ancillary  techniques increase  the sensitivity of  urine cytology  have been  
clinically  insignificant.   Several  bladder  tumour markers have  been  
investigated like  BTA, nuclear matrix  proteins,  fibrin  degradation products, 
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have lower specificity than urine  cytology  and  may  have  increase  false  
positive.  Telomerase  in  highly  sensitive  and specific, disadvantages as  not  
readily  available.  Hyaluronidase  and  hyaluronic  acid are  important  markers, 
but  does not  detect grade  I TCC. Combination of these tumour markers  
increases performance  status, allow  advantages of  one another, compared to 
bladder  tumour markers,  urine  cytology  will  remain  gold  standard 
screening  method  because of  comfortable  familiarity. 
Cystocopy  considered  gold  standard in diagnosing  for  recurrent 
urothelial  cell   carcinomas.  But  its  both invasive  and  costly. 
Cunder et al  shows  that  urinary  bladder urothelial  carcinoma 
diagnosed by  combination of  cytoscopy  and  biopsy  with  urine  cytology  as  
additional  technique. The accuracy  of  urine  cytology  varies  from one 
pathologist  to  another &   depend  upon experience of  pathologist.  In future 
new method  was  introduced  for  detection  of  cancer cells  in  urine. Flow  
cytometry was used  to  detect  protoporphyrin IX in  a  model consists  of  
normal bladder  transitional  epithelial  cells . Urine   samples  of  19 patients 
with histology proved bladder  cancer  were  examined.  Incubation  period of 
one hour in  normal bladder  cells or  TCC cells with  HAL   results in  
production   of  protophorphyrin IX  only in  TCC cells. Even  5% TCC cells 
can able  detect in mixture of normal/ transitional bladder  cells.  To   test  
feasibility  of  method in  clinical  diagnosis urine samples were  measured with 
comparable.  The  results show  that technique  may  be  feasible for  the  
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detection of  bladder  cancer  cells  in  urine with  advantages  of simplicity ,  
reliability  and  objectivity. 
      Bladder  cancer is  the most  common  malignancy  of  all  genitourinary  
tumours. Gold  standard  for  non- invasive bladder  cancer is  urine cytology 
but  senstivity  is  low.   
 
BLADDER CANCER 
        Transitional cell carcinoma or urothelial carcinoma accounts for 90% of all 
primary tumors of bladder. 
         Most bladder cancers appear as a focal or multifocal expression of 
widespread abnormality of urothelium, progression of which leads to 
multicentricity in space and recurrence in time. 
Clinical Presentation 
         Eighty percent of the patients with bladder carcinoma present with gross 
or microscopic, painless and intermittent hematuria. Twenty percent of patients 
will complain of vesical irritative symptoms including urinary frequency and 
urgency. It is important to consider CIS [Carcinoma In Situ.] in any patient with 
a history of irritative voiding symptoms. Patients with invasive bladder cancer 
may have abdominal tenderness or bladder mass or induration. 
Biologic Pathways 
          Two distinct pathways are suggested in urothelial neoplasia. A lowgrade 
pathway hypothesized in approximately 70% the of cases. It is characterized by 
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progression from hyperplasia/dysplasia to papilloma to low grade transitional 
cell carcinoma. The lesions have bland cytology and normal blood group 
isoantigens and are predominantly diploid. Recurrences are frequent and 
multiple, but only minority of the cases (10 to 15%) progress to muscle invasion 
           In the high grade pathway most invasive lesions arise without a history 
of papillary neoplasms. They progress directly from flat lesions of severe 
dysplasia/carcinoma in situ to invasive high grade transitional cell carcinoma 
and are associated with mortality. Such lesions have pleomorphic cytology, 
manifest high mitotic rates,lack normal blood group isoantigens,and are usually 
aneuploid11,50. 
         The flat carcinoma in situ may precede invasive carcinoma by months or 
years. A primary goal of urine cytology is to recognize these early flat lesions 
before they invade, as well as to detect the 10% of papillary lesions that are 
destined to invade11. 
Cytologic classification of urothelial malignancy 
General Principles of Cytologic Diagnosis 
       Higher the grade and the more extensive the tumor, greater the ability to 
make a cytologic diagnosis. Cells shed from transitional cell carcinoma in situ 
have a similar cytomorphology as high-grade invasive lesion. One cannot 
reliably determine whether a lesion is in situ or invasive cytologically. 
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Cellular features of urothelial neoplasia50,51 
 
Cells Low grade High grade 
Arrangements Papillary and loose clusters Isolated and loose clusters 
Size Increased, uniform Increased, Pleomorphic 
Number Often numerous Variable  
Cytoplasm Homogenous  Variable 
Nuclear cytoplasmic 
ratio Increased Increased 
Nuclei 
Position Extremely eccentric Eccentric 
Size Enlarged Variable 
Morphology Variable within aggregates Variable  
Borders Irregular Irregular 
Chromatin Fine Coarse 
Nucleoli Small Variable 
 
Differential diagnosis. 
           Differential Diagnosis includes atypia due to catheterization, cystitis, 
stones, radiation and  chemotherapy. 
Differentiating features of reactive cell, low grade and high grade TCC 
         High nuclear cytoplasmic ratio, irregular nuclear membrane, 
nonvacuolated cytoplasm  are three key features in the diagnosis of low grade 
transitional cell carcinoma42 
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Differentiating features of  Reactive cell, Low grade and High grade TCC44,50,51 
 
Feature Reactive Low grade TCC High grade TCC 
Groups Pseudopapillae Papillae, loose or crowded clusters 
Loose 
clusters/syncitia/single 
Cells Enlarged, pleomorphic variable in number. 
Enlarged, relatively 
uniform, often 
numerous 
Enlarged, pleomorphic 
N/C ratio Normal/increased Increased(slight to moderate) 
Increased(moderate to 
marked) 
Nucleus Central Eccentric, enlarged Eccentric, pleomorphic 
Nuclear 
membrane Smooth,thick 
Slightly irregular, 
thin 
Moderate to markedly 
irregular 
Chromatin Fine, even Granular, even Coarse, dark, irregular 
Nucleoli Often large Small to none Macronucleoli in many cells 
Cytoplasm Vacuolated Homogenous Often vacuolated also squamous 
Background Inflamed or clean Clean Diathesis 
 
 
Dysplasia 
          Dysplasia describes a flat, non-invasive premalignant lesion distinguished 
from reactive or reparative epithelium. The cytologic diagnosis of urothelial 
dysplasia is a point of contention. The cells are reported to have a lesser degree 
of cytologic atypia than transitional cell carcinoma in situ but are similar in 
appearance to cells from low-grade papillary neoplasms. The chief differences 
are the small number of dysplastic cells present in urinary specimens, the 
aggregation of cells into small but loose clusters, a lower N/C ratio [Nuclear 
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Cytoplasmic ratio] and fine evenly distributed chromatin. In truth urothelial 
dysplasia cannot reliably be segregated from low-grade TCC with subjective 
criteria of cytology alone. 
Papilloma 
           Papillomas are well-differentiated papillary transitional cell neoplasms. 
Many papillomas are composed of cells with normal or nearly normal 
morphologic appearance, making cytologic diagnosis difficult or impossible. 
Others have morphologic feature of low grade neoplasm. Therefore only 1/3rd  
to  2/3 rd of these lesions can be diagnosed cytologically and the higher 
diagnostic yield (fewer false negatives) comes at the expense of more false  
positive diagnosis50. 
         Numerous cells may be exfoliated. Loose clusters and papillary aggregates 
commonly occur, but must be differentiated from pseudopapillary clusters 
related to trauma, instrumentation, stones, etc. True papillary fronds with 
fibrovascular cores are diagnostic of papillary neoplasia. However, their 
presence is not essential for cytologic diagnosis. The cells and their nuclei are 
larger than normal deep transitional cells (but not superficial cells). The cell 
borders are often indistinct. The cytoplasm is homogeneous rather than 
vacuolated. The nuclei are eccentric and have slightly irregular membranes in 
the form of notches or creases. The chromatin is fine and evenly distributed. 
Nucleoli, if present, are small50,51. 
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Carcinoma in Situ: 
         A lesion in which transitional epithelium, of variable thickness, is 
composed of variably sized abnormal cells with significant nuclear and 
cytoplasmic abnormalities, limited to the epithelium and never crosses the basal 
layer. 
Squamous Cell Carcinoma 
       Squamous cell carcinoma can be accurately identified from cells in urine 
sample. They  are usually well differentiated and exfoliate fairly mature cells 
with an elongated, spindled or fusiform configuration. Cytoplasmic 
keratinization can often be distinguished. Nuclear border is irregular. Nuclear 
deformation is common. 
Adenocarcinoma 
          Primary adenocarcinomas are rare in the bladder. The adenocarcinoma 
cells tend to cluster and have poorly stained, lucent, vacuolated cytoplasm. 
Chromatin tends to aggregate along smooth nuclear borders and manifests. 
Nucleoli are prominent. 
Diagnostic correlation between cytologic and cystoscopic examination37. 
 
 
Cytology Cystoscopy Likely diagnosis 
(-) (-) No tumor 
(-) (+) Well differentiated papillary neoplasm 
(+) (-) Carcinoma in situ (or) upper tract tumor. 
(+) (+) High grade, invasive TCC 
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      Transabdominal ultrasonography has also been used to complement urine 
cytology in the  detection of bladder tumors. 
Pitfalls in urinary cytology 
 Over interpreting cells with low N/C ratio [Nuclear Cytoplasmic ratio] as  
 Cancer cells. 
 Mistaking papillary aggregates as a reliable sign of low grade neoplasia 
 Confusing the reactive/regenerative/reparative cell associated with 
urinary  
Stones with  neoplastic cells. 
 Over interpreting samples from the upper collecting system. 
 Misinterpreting cells in ileal conduits and 
 Misunderstanding the cytologic effects of drugs and X ray therapy. 
Morphologic features 
        TCC [Transitional Cell Carcinoma] can arise any where in the bladder. 
Common locations are: 
 Lateral walls 37% 
Posterior wall 18% 
Trigone 12% 
Neck 11% 
Ureteric orifices 10% 
Dome 8% and 
Anterior wall 4% 
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       Pattern of growth may be exophytic or endophytic or a combination of 
both. Exophytic tumor may adopt a papillary configuration (with central 
fibrovascular core) or a solid appearance (nodular). Exophytic tumor results in 
clusters of tumor cells in the lamina propria which may be under diagnosed as 
Von Brunn’s nests or cystitis glandularis or cystica. This is referred to as the  
nested variant of transitional cell carcinoma. 
       Stromal invasion by transitional cell carcinoma proceeds in two stages. 
Invasion of the lamina propria and invasion of muscle layer. Muscle invasion is 
of great consequence because of its influence on therapy and prognosis. Care 
should be exercised not to misinterpret the inconsistent but sometimes 
prominent fascicles of muscularis mucosa as belong to the muscularis propria. 
          It is also important not to misinterpret the mature adipose tissue 
commonly present in the lamina propria or muscularis propria as perivascular 
soft tissue, in order to avoid a tumor adjacent to fat in a biopsy specimen being 
badly overstaged. 
   The cyto architectural variations that may occur in transitional cell carcinoma 
are 
1. Foci of glandular metaplasia are common, usually in the form of intra-      
cytoplasmic  mucin containing vacuoles. 
2. Foci of squamous differentiation especially in high grade tumors may be   
seen. 
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3. Clear cells may be prominent in transitional cell carcinomia and simulate 
 adenocarcinoma. 
4. Micropapillary pattern may occur which resembles that of ovarian serous 
papillary carcinoma. 
5. Rare variant of TCC is characterized by a plasmacytoid appearance that 
mimics myeloma. 
Bladder Biopsy 
Transurethral Resection 
          Before tumors are resected, their location, number and size should be 
noted. Endoscopically visualised characterization with predictive value for 
disease progression include shape (papillary versus sessile and flat), size (less 
than 2 cm versus greater than 5 cm) and the presence of associated mucosal 
abnormalities. 
         Kenneth B. Cummings et al21 suggested hot loop resection of the tumor, 
after adequate biopsy mapping of bladder mucosa. He also insisted that the 
resection must include sufficient muscle to allow adequate pathologic staging. 
As an adjunct to hot loop resection, a cold up biopsy of the tumor edge or base 
can provide muscle for pathologic staging while reducing charring artifact and 
the risk of bladder perforation. Video cystoscopy, combined with continuous-
flow resectoscope, will allow safe resection in almost all cases. 
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Grading and Staging 
Grading of urothelial tumors18. 
WHO/ISUP  Grades   (World Health Organization/International Society of 
Urological   
Pathology). Adopted  as  WHO system   in 2004. 
Urothelial papilloma 
Urothelial neoplasm of low malignant potential 
Papillary Urothelilal Carcinoma, low grade 
Papillary Urothelial Carcinoma, high grade. 
WHO Grades (1973)  
Urothelial Papilloma 
Urothelial neoplasm of low malignant potential 
Papillary Urothelial Carcinoma, Grade 1 
Papillary Urothelial Carcinoma, Grade 2 
Papillary Urothelial Carcinoma, Grade 3 
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Histologic feature used to classify Urothelial Papillary lesions according to 
the scheme  proposed by the WHO/ISUP [The World Health Organization 
/ International Society of Urological Pathology]19. 
 
Architecture 
 Papilloma 
Papillary 
neoplasm of 
low malignant 
potential 
 
Low grade 
Papillary 
Carcinoma 
 
High grade 
Papillary 
Carcinoma 
 
Papillae Delicate 
Delicate, 
Occasionally 
Fused 
Fused, branching 
and delicate 
 
Fused, branching 
and delicate 
 
Organization 
of cells 
 
Identical 
to normal 
 
Polarity identical to 
normal; any 
thickness; 
cohesive 
 
Predominantly 
ordered, yet 
minimal 
crowding and 
minimal loss of 
polarity; any 
thickness; 
cohesive 
Predominantly 
disordered with 
frequent loss of 
polarity, any 
thickness; often 
discohesive 
 
. 
Histologic feature used to classify Urothelial Papillary lesions according to 
the scheme  proposed by the WHO/ISUP [The World Health Organization / 
International Society of  Urological Pathology]19. 
Cytology 
Nuclear 
size 
 
Identical to 
normal 
 
May be uniformly 
enlarged 
 
Enlarged with 
variation in size 
 
Enlarged with 
variation in size 
 
Nuclear 
shape 
 
Identical to 
normal 
 
Elongated, roundoval, 
Uniform 
Round-oval; slight 
variation in shape 
and contour 
Moderatemarked 
Pleomorphism. 
 
 
Nuclear 
Chromatin 
 
Fine 
 Fine 
Mild variation 
within and 
between cells. 
 
Moderatemarked 
variation 
both within and 
between cells 
with 
hyperchromasia. 
 
Nucleoli Absent 
Absent to 
inconspicuous 
 
Usually 
inconspicuous* 
 
Multiple 
Prominent 
nucleoli may be 
present 
Mitosos Absent Rare, basal 
Occasional, at any 
level 
 
Usually frequent 
at any level 
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                       URINE  CYTOLOGICAL  PICTUTRE 
 
 
 
 
 
 
 
 
 
     
                 
Urine  sediment smaer  shows  degenerated  cells  groups shoeing  
vacuolated Cytoplasm  and  degenerated nuclei. H&E  Stain  (400x) 
 
                          
     
 
                                  
 
 
 
 
 
 
 
 
 
 
 
 
 
              Urine sediment smear  of  low grade TCC.   Papstain   (400X). 
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Histology  of  lowgrade  papillary  TCC showing  branching, delicate  papillae    
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
Histology of  High  grade papillary  TCC showing  cells  with   pleomorphic 
hyperchromatic nuclei .  H & E. (400) 
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Histology  shows  carcinoma  in  situ  
 
 
 
 
 
 
 
 
 
 
 
Histology  shows  muscle  invasion in  TCC . H & E stain (400) 
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Pathologic T (Primary tumor) staging of bladder carcinoma18. 
 
AJCC/UICC Depth of invasion 
Non invasive, Papillary Ta  
Carcinoma in situ(Non invasive, flat) Tis  
Lamina Propria invasion 
 T1 
Muscularis Propria invasion 
 T2 
Microscopic extravesicle invasion 
 T3a 
Gross apparent extravesicle invasion 
 T3b 
Invades adjacent structures T4 
 
Regional Lymph Nodes (N) 
 
NX                   Lymph nodes cannot be assessed 
N0                    No lymph node metastasis 
N1                    Single regional lymph node metastasis in the true pelvis      
                        (hypogastric, obturator, external iliac, or presacral lymph node) 
N2                   Multiple regional lymph node metastasis in the true pelvis  
                       (hypogastric, obturator, external iliac, or  presacral lymph node) 
N3                   Lymph node metastasis to the common iliac lymph  nodes 
Distant Metastasis (M) 
       M0            No distant metastasis 
       M1            Distant metastasis 
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Ultrasonography 
           The most common sonographic appearance of TCC is hypoechoic mass 
in the renal collecting system that splits the central echocomplex with varying 
degrees of infundibular dilatation. Focal hypoechogenicity of adjacent renal 
cortex reflects local invasion. Occasionally, the central echocomplex may be 
only segmentally amputated.  
Ultrasonography is inaccurate for diagnosing early TCC,  useful in the 
diagnosis of obstructive uropathy. Ureteric lesions are particularly difficult to 
visualize unless they cause hydronephrosis and hydroureter. The other 
limitation of ultrasonography is that it is inaccurate in the staging of bladder 
TCC, particularly Ta and T1 tumors, and also in the detecton of pelvic lymph 
node involvement. 
On sonograms, calculi may be confused with high-grade TCCs, which 
can be densely echogenic. No sonographic features are specific for TCC, and 
many filling defects within the renal collecting system and bladder may have a 
nonspecific appearance. In addition, ultrasonography is limited in its capacity to 
depict nondilated ureters. 
Local spread and metastasis 
       Bladder carcinoma may extend into the ureters, neck of the bladder, 
urethra, prostatic ducts and seminal vesicle. 
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       Lymphnode metastasis in the pelvic chains are found in 25% of invasive 
tumors. The most common sites of distant metastatis are the lungs, liver, bone 
and central nervous system. 
Histochemical and Immunohistochemical features. 
       The co-ordinate expression of CK7 and CK20 is a feature of transitional 
cell carcinoma. CK20 positivity is common and strong in the high grade tumors. 
Thrombomodulin and Uroplakin III are two new useful markers for transitional 
cell carcinomia, but the former is not very specific and the later is only 
moderately sensitive. 
       Other markers commonly expressed by these tumors are CEA and 
cathepsin B (high grade tumors), CA19-9, CD15 (leu M1), survivin and 
androgen receptors. Deletion of ABO blood group antigen is a common finding 
in transitional cell carcinomas particularly in high grade tumors. 
          Staining for the basal lamina component laminin has been advocated for 
the detection of early stromal invasion. Tenascin an extra-cellular matrix protein 
is strongly expressed in invasive, high-grade carcinomas with abundant stroma 
and is thought to reflect both the severity of the inflammatory infiltrate and the 
extent of stromal  remodel 
 
            
 
                 
  
48 
 
ULTRASOUND  PICTURE   IN  CA  BLADDER 
 
 
 
 
 
Ultrasound  shows  multiple, sessile muscle invasive  tumours  
(Hyperechoic) 
                           
CYSTOSCOPIC  PICTURE 
 
Cystoscopy  shows  red, velvety  lesions (CIS),  well  seen  after  
fluorescence  cystoscopy 
 
 
 
  
 
 
MATERIALS  AND 
METHODS 
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MATERIALS AND METHODS 
 
1.Study group :   
          70  Patients who were admitted in Department of  Urology,  Kilpauk 
Medical College and Govt. Royapettah  Hospital in coordination  with  
Department of  Pathology, patients  presented with  lower urinary tract 
symptoms (LUTS) due to bladder transitional cell carcinoma detected by 
ultrasonography  were included in the  study 
 
2.Study design :  Prospective clinical study   
 
3.Study period :  One  Year  from  January 2014  to January 2015 
 
4.Materials : 
 
Freshly  voided urine samples are collected for cytological examination. 
Cystoscopy was performed in  all patients using rigid cystoscope and details of 
growth are noted. Material was obtained from TURBT biopsy , Radical 
Cystectomy specimen 
Freshly voided urine samples are collected usually  3 hours after first 
morning void.  Samples are immediately mixed with 95 % alcohol and kept in 
refrigerator till centrifuged. Approximately 100ml of urine are centrifuged at 
2500 revolution/min for 20 min. Multiple smears are prepared from sediment 
and slides  are fixed in 95% alcohol immediately.  
Smears are stained with papanicolaou stain and haematoxylene and eosin 
stain.  Interpretation of  exfoliative cytology of urinary sediments  are 
classifieds  as Negative, Atypia,  Suspcious, Positive 
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Biopsies taken are processed routinely  and 3-5 u thick sections are cut.  
H  & E Staining was done on tissue section for morphological evaluation  & 
lesions are  histologically  classified  as  Low grade,  High grade  & No 
malignancy 
 
Inclusion criteria 
 
• Patients  with  Bladder  Neoplasms  detected by  ultrasound 
 
• Symptomatic  patients with  LUTS  and  hematuria 
    
Exclusion criteria  
 
• Patients  who already  undergone  biopsy 
 
• Other causes  of  Hematuria  like  RCC, Upper tract TCC 
 
 
          Statistical  Analysis  was  performed  with  Statisticial  Package  for  the  
Social  Sciences (SPSS)  Version 15  software  using  Pearson’s  Chi-Square  
Test  and  Fischer’s  Exact  Test with  P <0.05  considered  to  indicate  
statistical  significance 
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OBSERVATION   AND   RESULTS 
 
70  patients of  urinary  bladder  neoplasms  diagnosed  by   
ultrasonography were   studied   for  comparative  evaluation  of  urinary  
cytology  with Histopathological  correlation.  The  findings  in  these patients  
have  been  presented as 
• Clincal  Data 
• Ultrasonography  and  Cystoscopic  Findings 
• Cytology  and   Histopathological  Report 
 
 
                           Table : 1  Age /Sex  wise Distribution 
 
AGE MALE FEMALE 
30-39 2 - 
40-49 10 2 
50-59 24 7 
60-69 16 3 
70-79 5 - 
80-89 1 - 
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CHART 1: Age /Sex  wise Distribution 
 
 
 
 
     
 
 
 
 
 
 
Among  our  study group,  Most  common  Age  Group – 50-59 Years 
(42%).  Male  to  Female  Ratio  was  4:1. Since age and Sex distribution are not 
statistically significant (>0.05), it means that there is no difference between the 
Urine Cytology Findings groups. In other words the groups contain subjects 
with the same basic demographic characteristics 
                                                                           
 
 
 
                                   
  
Age in Years 
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50% 
33% 
15% 
2% 
Hematuria, Dysuria,
Frequency
Hematuria  & Dysuria
 Hematuria  & Frequency
Dysuria   & Frequency
TABLE 2:  CLINICAL FEATURES 
 
CLINICAL  PRESENTATION NO  OF  PATIENTS 
Hematuria, Dysuria, Frequency 34 
Hematuria  & Dysuria 22 
Hematuria  & Frequency 10 
Dysuria   & Frequency 4 
 
 
CHART  2:  CLINICAL FEATURES 
 
 
 
 
 
 
 
 
 
 
 
By conventional criteria, association between Clinical Features 
Distribution and Urine Cytology Findings is considered to be not statistically 
significant since p 0-936. 
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TABLE :3  SMOKING  HISTORY 
SMOKING  HISTORY NO OF  PATIENTS PERCENT 
Smoker 
Non- Smoker 
Total 
53 
17 
70 
74% 
26% 
100% 
 
CHART :3  SMOKING  HISTORY 
 
Statisticial  Analysis 
Smoking Urine Cytology  -ve % 
Urine Cytology 
+ve % 
Smoking -ve 6 33.33 11 21.15 
Smoking +ve 12 66.67 41 78.85 
Total 18 100.00 52 100.00 
Chi Square Statistic 1.08 
Degrees of Freedom 1 
P value 
Chi Square Test 0.299 
 
By conventional criteria the association between Smoking Status and Urine 
Cytology Findings is considered to be not statistically significant since p > 0.05. 
53, 76% 
17, 24% 
SMOKER
NON-SMOKER
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TABLE : 4   URINE   CYTOLOGY 
URINE CYTOLOGY  
RESULTS NO  OF  CASES 
POSITIVE 44 
SUSPICIOUS 8 
ATYPICAL 4 
NEGATIVE 14 
 
CHART :4  URINE CYTOLOGY 
 
 
 
         In  our  study group, urine  cytology  were  positive  for  cancer cells in 
44(63 %), Suspicious in 8, (11%), Atypical  in 4 (6%),  Negative in 14(20%)  
patients 
 
                 
44 
8, 11% 
4, 6% 
14, 20% 
POSITIVE
SUSPICIOUS
ATYPICAL
NEGATIVE
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TABLE : 5  ULTRASONOGRAPHIC  FINDINGS 
TYPE  OF  LESION NO  OF  CASES PERCENTAGE 
HYPOECHOGENIC 44 60% 
MIXED  ECHOIC 16 17% 
HYPERECHOIC 6 8% 
ISOECHOIC 4 5% 
TOTAL 70 100% 
 
CHART : 5  ULTRASONOGRAPHIC  FINDINGS 
 
Statisticial  Analysis 
Ultrasound  Findings Urine Cytology -ve % 
Urine Cytology 
+ve % 
Hypoechogenic 8 44.44 36 69.23 
Mixed  Echoic 6 33.33 10 19.23 
Hyperechoic 4 22.22 2 3.85 
Isoechoic 0 0.00 4 7.69 
Total 18 100.00 52 100.00 
Chi Square Statistic 9.12 
Degrees of Freedom 3 
P value 
Chi Square Test 0.028* 
      
By conventional criteria the association between Ultrasound Findings and 
Urine Cytology Findings is considered to be statistically significant since                  
p < 0.05                                     
44 
16 
6 
4 
0 10 20 30 40 50
Hypoechoic
Mixed echoic
Hyper echoic
Isoechoic
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CHART 6: LOCATION  OF  LESIONS  IN   CYSTOSCOPY 
 
 
 
Table 6:  Statitiscial  Analysis 
Location of  Lesions Urine Cytology -ve % 
Urine 
Cytology +ve % 
Lateral Wall 12 66.67 26 50.00 
Posterolateral Wall 3 16.67 13 25.00 
Base & Neck ofBladder 2 11.11 8 15.38 
Dome of bladder 1 5.56 2 3.85 
Anterior Wall 0 0.00 3 5.77 
Total 18 100.00 52 100.00 
Chi Square Statistic 2.39 
Degrees of Freedom 4 
P value 
Chi Square Test 0.664 
   
 By  conventional criteria the association between Location of Lesions 
and Urine Cytology Findings is considered to be not statistically significant 
since p > 0.05.  
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CHART  7 : TYPE  OF  LESIONS IN CYSTOSCOPY 
 
 
Table7 :  Statisticial  Analysis 
 
Type of Lesions Urine Cytology -ve % 
Urine Cytology 
+ve % 
Pedunculated 9 50.00 17 32.69 
Sessile 9 50.00 35 67.31 
Total 18 100.00 52 100.00 
Chi Square Statistic 1.72 
Degrees of Freedom 1 
P value 
Chi Square Test 0.190 
 
By conventional criteria the association between Type of Lesions and 
Urine Cytology Findings is considered to be not statistically significant since p 
> 0.05. 
 
 
 
26 
44 
Type of Lesions 
Pedunculated Sessile
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CHART 8:  NUMBERS  OF  TUMOURS  IN  CYSTOSCOPY 
 
 
 
Table 8:   Statisticial  Analysis 
 
No of Tumours Urine Cytology  -ve % 
Urine Cytology 
+ve % 
Single 10 55.56 32 61.54 
Multiple 8 44.44 20 38.46 
Total 18 100.00 52 100.00 
Chi Square Statistic 0.199 
Degrees of Freedom 1 
P value 
Chi Square Test 0.655 
 
By conventional criteria the association between Number of Tumours and 
Urine Cytology Findings is considered to be not statistically significant since p 
> 0.05. 
 
42 
28 
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Chart  9 : SIZE  OF   TUMOUR   AT  CYSTOSCOPY 
 
 
 
TABLE  10:  COMPARISON OF  HISTOLOGY  WTIH  URINARY 
CYTOLOGY 
 
HISTOLOGY CYTOLOGY TOTAL 
POSITIVE NEGATIVE 
LOW  GRADE 16 7 23 
HIGH  GRADE 36 9 45 
NEGATIVE 0 2 2 
TOTAL 52 18 70 
 
     
 
  
10 
44 
16 
0
10
20
30
40
50
 Size > 2cm Size 2-5cm Size > 5cm
No  of  Patients 
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CHART 10 :  COMPARISON OF  HISTOLOGY  WTIH  URINARY  
CYTOLOGY 
 
Statistical Analysis 
Histological 
Diagnosis 
Urine Cytology 
-ve % 
Urine Cytology 
+ve % 
Negative 2 11.11 0 0.00 
Low Grade 7 38.89 16 30.77 
High Grade 9 50.00 36 69.23 
Total 18 100.00 52 100.00 
Chi Square Statistic 6.82 
Degrees of Freedom 2 
P value 
Chi Square Test 0.033* 
 
P  value  -  Significant 
Statistical Significance 
 
• In simple terms, the incidence of High Grade Histological Positivity is 
50% in Urine Cytology –ve Group compared to 69.23% in Urine 
Cytology +vegroupwith a p-value of 0.033 according to Chi-Squared test. 
• This indicates that there is a true difference among the study groups and 
the difference is significant and has not occurred by chance. 
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TABLE 11:  COMPARISON  OF URINARY  CYTOLOGY  WITH  
TUMOUR  STAGING 
 
URINE  
CYTOLOGY PTa, PTis PT1 
PT2  &  
Above 
Positive 4 15 12 21 
Negative 6 6 2 4 
Total 10 21 14 25 
 
 
CHART 11:  COMPARISON  OF URINARY  CYTOLOGY  WITH  
TUMOUR  STAGING 
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Statisticial  Analysis 
Tumour  Staging Urine Cytology -ve % 
Urine Cytology 
+ve % 
Pta 6 33.33 4 7.69 
Ptis 6 33.33 15 28.85 
PT1 2 11.11 12 23.08 
PT2 & Above 4 22.22 21 40.38 
Total 18 100.00 52 100.00 
Chi Square Statistic 8.44 
Degrees of Freedom 3 
P value 
Chi Square Test 0.038* 
                                             
By conventional criteria the association between Tumour Staging and 
Urine Cytology Findings is considered to be statistically significant since p < 
0.05. 
 
TABLE :12  COMPARISON  OF  URINE   CYTOLOGY  WITH 
DIFFERENT  HISTOLOGY 
 
HISTOLOGY 
URINARY  CYTOLOGY 
POSITIVE NEGATIVE 
TCC 52 16 
ADENOCARCINOMA 0 2 
TOTAL 52 18 
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CHART  12:  COMPARISON  OF  URINE   CYTOLOGY  WITH 
DIFFERENT  HISTOLOGY 
 
 
 
Statistical  Analysis 
 
Type of Tumour Urine Cytology -ve % 
Urine Cytology 
+ve % 
TCC 16 88.89 52 100.00 
Adenocarcinoma 2 11.11 0 0.00 
Total 18 100.00 52 100.00 
Chi Square Statistic 5.95 
Degrees of Freedom 1 
P value 
Chi Square Test 0.015* 
                               
By conventional criteria the association between Types of Tumour and 
Urine Cytology Findings is considered to be statistically significant since p < 
0.05. 
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Accuracy Statistics 
 
Histological Diagnosis Positive Negative Total 
Urine Cytology +ve 52 0 52 
Urine Cytology -ve 16 2 18 
Total 68 2 70 
 
 
Accuracy Statistics  
Sensitivity 96% 
Specificity 26% 
Positive Predictive Value 76.5% 
Negative Predictive Value 90% 
Likelihood Ratio +ve 1.13 
Likelihood Ratio -ve 0.00 
Diagnostic Effectiveness 0.77 
Prevalence 0.74 
 
• Sensitivity of Urine Cytology study findings is High, meaning that 
malignancy +ve test result often occurs in those with malignancy 
• Specificity of Urine Cytology study findings is extremely low, meaning 
that malignancy –ve test very rarely occurs in those without malignancy 
• The diagnostic effectiveness or diagnostic accuracy is very high. It means 
that the overall value of Urine Cytology studyin detecting malignancy as 
a combined screening and case-finding test is good 
• Prevalence of this condition is very common 
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CYTOLOGICAL  PICTURE 
 
 
 
 
 
 
 
 
 
  
 
 
 
Urine  sediment smear of low grade TCC.  H&E   (400X) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Histology  of  low  grade  papillary TCC  showing  papillary  
structure with orderly arranged  cells. H&E. (400) 
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HISTOLOGICAL PICTURE 
 
 
 
 
 
 
 
 
 
 
 
 
Histology of  high grade  papillary TCC.  H&E (100X). 
 
 
 
 
 
 
 
 
 
 
 
         
Histology  of  TCC with muscle invasion. H&E (400X) 
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Ultrasound  picture  shows  non  muscle invasive tumours  over  Right  
lateral wall of  bladder (hypoechoic) 
 
 
 
Cystoscopy  shows  non-muscle invasive  and  muscle invasive  tumours 
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ANALYSIS    
In our Prospective  clinical  study,  totally  70 patients  were  included 
those  who are  presented  with  Lower  urinary  tract symptoms  due  to Bladder  
TCC  detected  by  ultrasound.  Age  of  patient  ranged  from 40 to 89. Most 
common  age  group   50-59 years ( 49%).  Male  to  Female  ratio – 4:1 
           The main  clinical  presentations  were  hematuria, dysuria  &  increased  
frequency  of  micturition .  Most   patients   about 34,  presented with  features 
of  hematuria,  dysuria,  &  Frequency of  micturition.   22  patients  presented  
with hematuria  &  dysuria,  10  patients  with hematuria  &  frequency of  
micturition.  Only  4  patients presented  with  dysuria  &  frequency  of  
micturition. 
            Out  of  70  cases,  74% were smokers,  remaining  26%  were  non-
smoker.  The  smokers  were  found  to  be  more  prone  to  develop  neoplastic  
lesion in bladder.   Urine  cytology were  positive for  cancer cells in  44(63%),  
suscipious  in  8(11%),  Atypical in 4(6%),  and  negative  in  14 (20%).  For  
comparative  study   with  histopathological  correlation,  positive cytology  &   
were suscipious  grouped as  Positive,   Atypical  &  Negative  were  grouped   
as  Negative. 
             Lesions in ultrasound  in  bladder  TCC  were  mostly  hypoechoic  of  
which  some were irregular,  some  lobulated  and  some pedunculated.   Most  
of  lesions are  multiple  &  few are  single.    Hypoechoic  lesion  were 
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followed  by  mixed  echoic,  few  hyperechoic  in  decreased order of  
frequency. 
            Statisticaly incidence of USG hypoechogenic lesions is 44.44% in Urine 
Cytology –ve Group compared to  69.23% in Urine Cytology +ve group  with a 
p-value of 0.028 according to Chi-Squared test. This indicates that there is a 
true difference among the study groups and the difference is significant and has 
not occurred by chance 
          In cystoscopy,   lesions  were  mostly  situated  in  lateral  wall  in  38  
cases, followed   by   Postero-lateral,  base  &  neck  of  bladder,  dome  of  
bladder  and  anterior  wall  respectively. The association between location of 
Lesions and Urine Cytology Findings is considered to be not statistically 
significant since p > 0.05. 
           Our  study  shows Most  of lesions  are  sessile (60%),  followed by 
pedunculated  (40%). Multiple tumours  are  present  in  28  cases,  single 
tumours  in 48  cases.  Likewise,  tumour   size  < 2cm  present   in  10  cases,  
2-5cm  seen in 44 cases,  > 5cm in 16 patients.  Cytopositivity   was  found to 
more  with single, large &  sessile tumours than  multiple, small pedunculated  
tumour.  Size  of  tumour  increase  with  increase in  cytopositivity.  When  
tumour  size   >5cm &  above  there is  about  90-100%   cytopositivity  was  
observed. The association between Number &  size  of  Tumours and Urine 
Cytology Findings is considered to be not statistically significant since p > 0.05. 
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           In our study  group,  among  70  cases,   68  cases were confirmed  
histologically, of  which 24  cases of  low  grade TCC,  44  cases  of  High  
grade TCC, only  2  cases are histologically  negative.  
         Out of  68  cases  of histologically proved TCC,  52  cases   were  
correctly  diagnosed  by  urine cytological   examination.   Only  16  cases  have  
cytological negative,  2 cases cytological  negative due  to  benign  disorder  
like  papillary  cystitis. Among  cytological  negative  16 cases,  10  cases  were 
diagnosed as  low  grade  in histopathology 
           Histological  confirmed  High  grade TCC in  44 patient,  of  which  36  
patient  were  detected   cytological  i.e (86%) detected  by  cytology. 
Histological confirmed low grade  TCC  occur in  24  patients  of  which  16 
patients  were  detected  cytologically  (58%).  Finally   histological  confirmed 
TCC  occur  in  68 patients  on  which  52 patients  were  diagnosed   
cytologically (76%).  Statistically  the incidence of High Grade Histological  
Positivity  is 50% in Urine Cytology –ve  Group compared to 69.23% in Urine 
Cytology +ve group with  a p-value of 0.033 according to Chi-Squared test. 
This indicates that there is a true difference among the study groups and the 
difference is significant and has not occurred by chance. Statistically  P value- 
0.033  is  significiant  
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In our  study  group, consists of  10 patients of  PTa,  21  patients  of  
carcinoma in situ PTis,  14  patients  invaded  subepithelial connective  tissue  
PT1,   25  patients   have  muscle  invasive  PT2   &  above.  Urine  cytology  
was  positive in  4 cases of  PTa,  15  cases  of  Tis,  12  cases of  PT1,  21  
cases of  PT2  & above. In  6  cases of  PTa,  6 cases of  PTis, 2  cases of  PT1, 
4 cases of  PT2 &  above staging  were found to  have  urine cytology  negative. 
About   80% of  noninvasive Tumour  had  negative  urine  cytology. 
Statisticially  the incidence of PT 2 and above Tumour Staging  is 22.22% in 
Urine Cytology –ve Group  compared to 40.38%  in  Urine Cytology +ve 
groupwith a p-value of 0.038 according to Chi-Squared test. This indicates that 
there is a true difference among the study groups and the difference is 
significant and has not occurred by chance . Cytopositivity  increases  with  
increase  in  Grade  &  Stage  of tumour. 
                  Out  of  70  patients   histologically ,  68  patients  had  varying   
grades  of   Bladder  Transitional  cell  carcinoma,  2 Patients  had   
adenocarcinoma . Incidence of T-cell Carcinoma type  is 88.99% in Urine 
Cytology –ve   Group compared to 100% in Urine Cytology +ve group with a   
p-value of 0.015 according to Chi-Squared test. 
 
 
                                                       
  
 
 
DISCUSSION 
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DISCUSSION 
 
           Urine   cytology   is  a  non invasive  method  of  detection,  diagnosis  
and  follow  up of  bladder   transtitional cell  carcinomas.  Urine  cytology  
involves  exfoliated cells  from  lining of   urinary  tract. Specimen  collected    
from  voided urine and  should  be  processed immediately  or  refrigerated as  
soon  as possible. It  can be  useful investigation  for  individuals  with  
hematuria,  has been  own   draw backs.  
         Urine cytology  relies on  neoplastic  cells  being  shed  in  urine.  High  
grade  tumours like  CIS  are  more  likely  to  shed  abnormal  cells into urine. 
Sensitivity  rates  are  higher  for high  grade  tumours.   Low  grade  tumours  
are  less likely  to shed cells  into  urine   and  less  sensitivity.  Exfoliated  cells 
are usually  shed  in  clusters  rather than  single cells.  False  positive    due  to  
stones , infections,  instrumentation and  chemo/radiotherapy .    
        Urine  cytology  reported  as  suscipous of  malignancy  require  further  
evaluation. Most  of  these  studies  shows  that outcome  of  patients having  
atypical  urine  cytology  shows   that  less  than  50% of  individuals are  30%  
are  found  to have  malignancy.  It  requires   further  follow  up, currently large  
number of  patients  are  subjected to  unnecessary  investigations  with  time  
and resources lost.    
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            Patients   were  selected  on  basis of  clinical  features   and  
ultrasonographic   features.  Only  those  cases  diagnosed  as  urinary  bladder  
lesions  by  USG  were  included  in  the  study.   Out  of  70  cases,  age  of  the  
patients   ranged  from 40-80 years  and  most  of  the patients  were in sixth 
decade of life.  The  male  to  female  ratio  was 4:1. 
         The most  common clinical  presentations  were  hematuria,  dysuria and 
increased  frequency  of micturition   followed   by presented  with  hematuria  
&  dysuria,  hematuria  and  frequency of  micturition.  
         Most  of   the  patients  in  the  study  were  smokers.  Out  of 70, smokers 
were  majority in  about  74%. So  there was  strong  association  between  
smoking  and  bladder  neoplasms 
          The lesion in  ultrasonography  were  mostly  hypoechoic  (42), of  which  
some  where  irregular,  lobulated,  pedunculated. Some  of  the  lesions  were  
multiple  and  few  are  single.   This  was  followed  by mixed  echoic  masses, 
hyperechoic  and  isoechoic lesions. Its Clinical Significance, incidence of 
USG hypoechogenic lesions was meaningfully 24.79 percentage points  more  
in Urine Cytology +ve  group compared to Urine Cytology –ve group In our 
study  Urine Cytology Positivity leads to 1.56 times increase in occurrence of 
USG hypoechogenic lesions 
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          Urine samples  are  freshly  whole voided   post  ambulatory  specimen, 
collected  randomly  and  processed  immediately. After  detection of  growth  
by  USG,  cytology  as  a screening  technique.   
        To  detect  malignant lesions  by  cytology  depend upon  morphological  
features  of  atypical  cells namely  cellularity,  clusters, papilla,  alteration  in  
cell  type,  shape, size, comet  cells , necrosis,  nuclear membrane  irregularity,  
high  N:C  ratio and  nuclear  hyperchromasia Urine  cytology were  positive for  
cancer cells in  44(63%),  suscipious  in  8(11%),  Atypical in 4(6%),  and  
negative  in  14 (20%).  For  comparative  study   with  histopathological  
correlation,  positive cytology  &  were suscipious  grouped as  Positive,   
Atypical  &  Negative  were  grouped   as  Negative. 
       The  macroscopic appearance  of  growth  in  bladder  cystoscopy  were  
mainly  sessile  followed  by  pedunculated.  About   48  cases  are single  and  
28  cases  are multiple.  Most  of lesions  were  situated  in  lateral  walls, 
namely  right  and   left  lateral walls.  The  remaining  were   located  in  
postero lateral,  base & neck   and  dome  of  bladder.   The  patients who have  
lesions in  base  and  neck  of bladder  presented  with  increased  frequency  of  
micturition. 
            Likewise,  tumour  size < 2cm  present   in  14%,  2-5cm  seen in  62%,    
> 5cm in  22%  patients.  Cytopositivity   was  found to more  with single , large 
&  sessile tumours than  multiple, small pedunculated  tumour.  Size  of  tumour  
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increase  with  increase in  cytopositivity.  When  tumour  size   >5cm &  above  
there is  about  90-100%   cytopositivity  was  observed . 
           In our study  group,  among  70  cases,   97%  were confirmed  
histologically, of  34% which of  low  grade TCC,  63%  of  High  grade TCC, 
only  2  cases are histologically  negative.  
         Out of  68  cases  of histologically proved TCC,  72%  were  correctly  
diagnosed  by  urine cytological   examination.   Only  25%  cases  have  
cytological negative,  2 cases cytological  negative due  to  benign  disorder  
like  papillary  cystitis. Among  cytological  negative ,38% were diagnosed as  
low  grade  in histopathology. 
             Histological  confirmed  High  grade TCC in  44 patient,  of  which  
86% patient  were  detected   cytological  . Histological confirmed low grade  
TCC  occur in  24  patients  of  which 58%  patients  were  detected  
cytologically.  Finally   histological  confirmed TCC  occur  in  68 patients  on  
which  76% patients  were  diagnosed  cytologically. It’s Clinical Significance 
the incidence of High Grade Histological Positivity was meaningfully 19.23 
percentage points  more  in Urine Cytology +ve  group compared to Urine 
Cytology –ve group . Urine Cytology Positivity leads to 1.38 times increase in 
occurrence of High Grade Histological Positivity. Our study conclude that 
Urine Cytology Positivity can predict an increasing trend of High Grade 
Histological Positivity 
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In our  study  group,   Urine  cytology  was  positive in  7% cases of  PTa,  
28% cases  of  Tis,  23% cases of  PT1, 40%  cases of  PT2  & above.. About   
80% of  noninvasive Tumour  had  negative  urine  cytology. Its Clinical 
Significance the incidence of PT 2 and above Tumour Staging was 
meaningfully 18.16 percentage points  more  in Urine Cytology +ve  
groupcompared to Urine Cytology –ve group. Urine Cytology Positivity leads 
to 1.82 times increase in occurrence of PT2 and above Tumour Staging. Our   
study conclude that Urine Cytology Positivity is detrimental in nature and  can 
lead to an increasing trend of Higher levels of tumour staging 
 
          Out  of  70  patients   histologically,  68  patients  had  varying   grades  of   
Bladder  Transitional  cell  carcinoma,  2 Patients  had adenocarcinoma. Its 
Clinical Significance the incidence T-cell Carcinoma type was meaningfully 
11.1 percentage points  more  in Urine Cytology +ve  group compared to Urine 
Cytology –ve group. Urine Cytology Positivity leads to 1.12 times increase in 
occurrence of T-cell Carcinoma type. Our study group  conclude that Urine 
Cytology Positivity is detrimental in nature and  can lead to an increasing trend 
of  Transtitional  cell  Carcinoma type 
Stromal  invasion  by   urothelial  carcinoma  proceeds  in two  stages, 
invasionof  lamina propria  and  invasion  of  muscle  layer.   Muscle  invasion  
found in 25  cases 
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           Urothelial  bladder  malignancies  diagnosed   by  combination  of  
cystoscopy  and biopsy,  with  cytology  as  a screening  procedure. Accuracy  
of cytological  diagnosis  depend upon  experience  and  vary  from  cone  
cytologist  to another. Cytological findings  alone cannot  be  diagnostic in  
many cases,  they  require clinical and  radiological findings  also.  
        Urine  cytology  is  used  for  diagnosis of  clinical  symptomatic  patients,  
detection of  tumours  in  high  risk  patients  those who  exposure  to  industrial  
chemicals,  smoking.  Cytology  only  complements,  does not  replace  
cystoscopy  and  biopsy.   Cytology  useful  in  detection in  small  or hidden  
lesions   like  diverticulum,  ureters,  renal  pelvis,  urethra.   
           Incidence   of urothelial  carcinoma  increases,  so  demand for  urine  
cytology  increases. Clinical  history  is  important to  minimise  false  positive .  
Urine  cytology  sensitivity  increases  with  grade of  tumour 
       To  conclude  that   sensitivity  of  urine  cytology  was  96%    where   as   
specificity  was    26% . Sensitivity   for  high  grade  tumous  was  higher  than   
low  grade tumours.  Its Diagnostic Significance,  Sensitivity of   Urine 
Cytology study findings is High, meaning that malignancy +ve test result often 
occurs in those with malignancy. Specificity of Urine Cytology study findings is 
extremely low, meaning that malignancy –ve test very rarely occurs in those 
without malignancy. 
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The PPV of Urine Cytology study findings are modest, meaning false 
positives are little common in those who screen positive. The NPV of Urine 
Cytology study findings is very high, meaning false negatives are rare  in those 
who screen negative. 
LH ratio for positive test is high, meaning that the test is more indicative 
of malignancy. It is good in ruling-in malignancy .LH ratio for negative test is 
not very low,  meaning that it is more likely the negative test result is to occur in 
a patient than in a subject without disease. It is not good in ruling-out 
malignancy 
           The diagnostic effectiveness or diagnostic accuracy is very high. It 
means that the overall value of Urine Cytology study in detecting malignancy as 
a combined screening and case-finding test is good.  Prevalence of this 
condition is very common. Our study  shows  that  cyto - histological  
correlation was 76%. 
       Although   specificity for  urine  cytology is  low,  its  high  sensitivity 
shows still a  valuable  tool  in  diagnosis  of  bladder  carcinoma,  where  newer  
modalities  have  not yet  been  established.  Larger   studies   may  be  required  
to better  study  specificity  and  sensitivity of  urine  cytology.    
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CONCLUSION 
 
 
• Cytological examination of urine specimen is valuable as an aid in the 
diagnosis of  bladder tumors. 
• Voided urine cytology correlates with histological diagnosis in more than 
60% of cases. 
• Accuracy is more with high grade tumors 
• Urine cytology grading correlates in most cases with histopathological 
grading. 
• The voided urine cytology is not only of diagnostic, but also of 
prognostic value; positive cytology of high grade presumably identifies 
patients at high risk for high grade and invasive tumours. 
• Cystoscopy is essential in diagnosing low grade tumors which were 
mostly missed by voided urine cytology. 
• Voided urine cytological study can be a valuable adjunct to the clinician 
in the evaluation of suspected urothelial malignancy, as it is simple, non-
invasive and with  good accuracy in the diagnosis of TCC. 
 
 
 
 
 
  
 
 
BIBLIOGRAPHY 
 
 
 
 
 
 
81 
 
                                              BIBLOGRAPHY 
 
1. A Desgrippes, V. Izadifar, J. Assailly ,E. Fontaine and D. Beurton : 
Diagnosis and prediction  of recurrence and progression in superficial 
bladder cancer with DNA image cytometry and  urinary cytology. British 
Journal of Urology International, 85, 434 - 436, 2000. 
2. Ahmad orandi and Mehdi Orandi: Urine Cytology in the detection of 
 bladder tumor recurrence. The Journal of Urology 116: 568 - 569, 1976. 
3. A.Saad, D.C. Hanbury, T.A.McNicholas, G.B. Boustead, S.Morgan and 
A.C.Woodman : A Study comparing various noninvasive methods of 
detecting bladder cancer in urine. British Journal of Urology 
International,89,39 - 373, 2002. 
4. Asitava Mondal, Dipak K Banerjee : The Reliability of Urinary Cytology 
in the Detection of Tumours of Urinary Bladder. Journal of Indian 
Medical Association, 90: 265 - 267, 1992. 
5. Culling C.F.A : Exfoliative Cytology and chromosome techniques. 
Handbook of Histopathological and Histochemical techniques. Ed: 3, 
page-492, Pub:Butterworths, 1974. 
6. David M. Schwalb, Harry W. Herr and William R. Fair: The 
Management of Clinically  Unconfirmed Positive Urinary Cytology. The 
Journal of urology 150: 1751-1756, 1993. 
7. DiBonito L, Musse MM, Dudine S, et al: Cytology of Transitional-Cell 
Carcinoma of the Urinary Bladder: Diagnostic Yield and Histologic 
Basis. Diagn Cytopathol 8: 124-127, 1992. 
8. Edward M Messing, Urotherial tumors of the Urinary tract. Campbell’s 
Urology, Walsh  Retik, Vaughan Wein: Ed: 8, Vol: 4,page 
2754.Pub:Saunders, 2002. 
 
82 
 
9. E. Piaton, K Hutin, J Faynel, M-C Rachin and M Cottier : Cost 
efficiency analysis of  modern cytocentrifugation methods versus liquid 
based (Cytyc Thinprep) processing of  urinary samples. Journal of 
Clinical pathology 57: 1208-1212, 2004. 
10. Farrow GM: Urine Cytology in the Detection of Bladder Cancer: A 
Critical Approach. J  Occup Med 32: 817-821, 1990. 
11. Felix.M.Brown : Urine Cytology Is it still the gold standard for 
screening? Urologic Clinics of North America 27: 25 - 37, 2000. 
12. Frable WJ, Paxson L, Barksdale JA, et al: Current Practice of Urinary 
Bladder Cytology.  Cancer Res 37: 2800-2805, 1977. 
13. Harry Suprun and Wilhelm Bitterman: A Correlative Cytohistologic 
Study on the  Interrelationship Between Exfoliated Urinary Bladder 
Carcinoma Cell Types and the Staging  and Grading of These Tumors. 
Acta Cytolgica 19: 265-273, 1975. 
14. Helene G. Wiener, G. Peter Vooijs, Bep van't Hof-Grootenboer : 
Accuracy of Urinary Cytology in the Diagnosis of Primary and Recurrent 
Bladder Cancer. Acta Cytolgica 37: 163- 169, 1993 
15. H.G.Wiener, CH Mian, A. Haitel , A Pycha, G. Schatzl and M 
Marberger. Can urine  bound diagnostic tests replace cystocopy in the 
management of bladder cancer. The Journal of Urology 159: 1876 - 1880, 
1998. 
16. Jae Y. Ro, Gregg A. Staerkel and Alberto G. Ayala: Cytologic and 
Histologic Features of  Superficial Bladder Cancer. Urologic Clinics of 
North America 19: 435-453, 1992 
17. J.N.Eble, R.H.Young: Tumor of the Urinary tract; Diagnoistic 
Histopathology of tumors; Christoper D.M. Fletcher, Ed: 2, Vol: 1, 516-
517, Pub: Churchill Livingstone, 2000. 
 
83 
 
18. Jonathan I. Epstein: The lower Urinary Tract and Male Genital System. 
Robbins and  Cotran Pathologic Basis of Disease. Vinay Kumar, Abul K 
Abbas, Nelson Fausto. Ed: 7, 1028 - 1033, Pub: Saunders, 2004. 
19. Juan Rosai: Urinary tract (Bladder). Rosai and Ackerman’s Surgical 
Pathology. Juan Rosai. Ed: 9, Vol: 1, 1327 - 1337, 2913-2914. Pub: 
Mosby, 2004. 
20. Kannan V: Papillary Transitional-Cell Carcinoma of the Upper Urinary 
Tract: ACytological Review. Diagn Cytopathol 6: 204-209, 1990 
21. Kenneth B Cummings, Joseph G. Baron and W. Steven Ward. 
Diagnosis and staging of Bladder cancer. Urologic Clinics of North 
America 19: 455 - 465, 1992. 
22. K.J.Hastie, R Ahmad and C.U Moisey: Fractionated Urinary Cytology in 
the Follow-up of  Bladder Cancer.British Journal of Urology 66: 40-41, 
1990. 
23. Lage JM, Bauer WC, Kelley DR, et al: Histological Parameters and 
Pitfalls in the Interpretation of Bladder Biopsies in Bacillus Calmette-
Guerin Treatment of  Superficial  Bladder Cancer. J Urol 135: 916-919, 
1986.  
24. Leopold G. Koss, Daniel Deitch, Ramesh Ramanathan and Andrew B. 
Sherman: Diagnostic Value of Cytology of Voided Urine. Acta Cytolgica 
29: 810-816, 1985 
25. Lucien E.Nochomovitz, Nabia E. Metwalli, Prabodh Gupta: The renal 
pelvis, ureter,  urinary bladder and urethra. Priniciples and practice of 
surgical pathology and cytopathology: Steven G. Silverberg, Ronald A 
DeLellis, William J Frable. : Ed 3, Vol 3,2209-2213., Pub: Churchill 
Livingstone Inc, 1997. 
26. Marilyn Gamble and Lan Wilson. The Hematoxylins and Eosin. Theory 
and practice of  Histological Techniques, John D Bancroft, Marilyn 
Gamble, Ed: 5, page 130. Pub: Churchil Livingstone, 2002. 
84 
 
27. Meyer M. Melicow. The Role of urine in a patient with a bladder 
neoplasm. The Journal of Urology 127: 660 - 664, 1982. 
28. Misra v, Gupta SC, Tandon SP, Gupta AK, Sircar S: Cytohistological 
study of Urinary  bladder neoplasms. Indian J Pathol Microbiol 43: 303-
309, 2000. 
29. MMTR - Madras Metropolitan Tumor Registry. National Cancer Registry 
Program. Indian Council of Medical Research, Cancer Institute, Chennai 
2005. 
30. M.N.EL-Bolkainy: Cytology of bladder carcinoma. The Journal of 
Urology 124: 20 - 22, 1980. 
31. Murphy WM: Falsely Positive Urinary Cytology: Pathologist's Error or 
Preclinical Cancer?  J Urol 118: 811-813, 1977. 
32. Nathan Lieberman, Philip G. Cabaud and Frank C. Hamm: Value of 
the Urine Sediment  Smear for the Diagnosis of Cancer. 89: 514-519, 
1963. 
33. Niels Harving, Hans Wolf and Fleming Melsen: Positive Urinary 
Cytology After Tumor  Resection: An Indicator for Concomitant 
Carcinoma In Situ. The Journal of Urology 140: 495- 497, 1988. 
34. Peter Anthony Berlac and Hans Henrik Holm: Bladder Tumor control 
by abdominal ultrasound and urine cytology. The Journal of 
Urology,147:1510-1512,1992. 
35. Planz B, Jochims E, Deix T, Caspers HP, Jakse G, Boecking A. The 
role of urinary cytology for detection of bladder cancer. Eur J Surg 
Oncol. 31:304-308, 2005 
36. P.N. Cowen: False Cytodiagnosis of Bladder Malignancy due to Previous 
Radiotherapy. British Journal of Urology 47: 405-412, 1975. 
37. Richard M DeMay American Society of Clinical Pathologists. Chicago. 
ASCP Prees: 1999. 
85 
 
38. Rife CC, Farrow GM, Utz DC: Urine Cytology of Transitional Cell 
Neoplasms. Urologic Clinics of North America 6: 599-612, 1979. 
39. Robert A. Badalament, Dane K Hermansen , Mark Kimmel et al : The 
Sensitivity of  Bladder Wash Flow Cytometry, Bladder Wash Cytology, 
and Voided Cytology in the Detection  of Bladder Carcinoma. Cancer 60: 
1423-1427, 1987. 
40. Sanjay Ramkumar, Jalaluddin Bhuiyan, Jennifer A Besse, Steven G. 
Roberts, Peter C. Wollan, Michael L. Blute and Dennis J O’Kane. 
Comparison of screening methods in the  detection of Bladder cancer. 
The Journal of Urology 161: 388-394, 1999. 
41. Sheldon Bastacky, Stackey Ibrahim, Sharon P.Wilczynski and William 
M. Murphy : The Accuracy of Urinary Cytology in Daily Practice: 
Cancer Cytopathology 87: 118 - 128, 1999. 
42. Stephen S Raab, Julia C.Lenel, Michael B. Cohen : Low Grade 
Transitional Cell Carcinoma of the Bladder. Cytologic Diagnosis by Key 
Features as Identified by Logistic  Regression Analysis. Cancer 74: 1621-
1626, 1994. 
43. Tawfik Zein, Zev Wajsman, Lenore S. Englander, Marie Gamarra, et 
al: Evaluation of  bladder washings and urine cytology in the diagnosis of 
bladder cancer and its correlation with  selected biopsies of the bladder 
mucosa. The Journal of Urology 132: 670 - 671, 1984. 
44. Uma A.Shenoy, Thomas V. Colby and G. Berry Schumann : Reliability 
of Urinary  Cytodiagnosis in Urothelial Neoplasms. Cancer 56: 2041- 
2045, 1985 
45. Vaidehi Kannan, Shikha Bose: Low Grade Transitional Cell Carcinoma 
and Instrument  Artifact: A Challenge in Urinary Cytology.Acta 
Cytolgica 37: 899-902, 1993. 
46. V.Poulakis, U.Witzsch, R. DE Vries, H-M. Altmannsberger et al. A 
comparison of urinary  nuclear matrix protein - 22 and bladder tumor 
86 
 
antigen tests with voided urinary cytology in  detecting and following 
bladder cancer: the prognostic value of false-positive results: British  
Journal of Urology International 88: 692- 701, 2001 
47. Wallace DMA, Smith JHF, Billington S, et al: Promotion of Bladder 
Tumours by  Endoscopic Procedures in an Animal Model. British Journal 
of Urology 56: 658-662, 1984. 
48. Weldon TE, Soloway MS: Susceptibility of Urothelium to Neoplastic 
Cellular Implantation.Urology 5: 824-827, 1975. 
49. William M Murphy, William N Crabtree, Alina F Jukkola and Mark S. 
Soloway: The Diagnostic Value of Urine Versus Bladder Washing in 
Patients With Bladder Cancer.The  Journal of Urology 126: 320-322, 
1981. 
50. William M Murphy, Mark S Soloway , Alina F Jukkola , William N. 
Crabtree and  Kimball S. Ford: Urinary Cytology and Bladder Cancer: 
The Cellular Features of Transitional  Cell Neoplasms. Cancer 53: 1555-
1565, 1984. 
51. William M Murphy: Current Status of Urinary Cytology in the 
Evaluation of Bladder  Neoplasms. Human Pathology 21: 886-896, 1990. 
52. William N. Crabtree, William M Murphy : The Value of Ethanol as a 
Fixative in Urinary Cytology. Acta Cytolgica 24: 452-455 
 
 
 
 
 
 
 
 
 
  
 
 
ANNEXURES 
 
 
 
 
 
ANNEXURE 1
 
 
 
ANNEXURE  - 2 
     
 
PROFORMA 
 
 
NAME:                                            AGE:                                         SEX: 
 
 
ADDRESS:                                      IP.NO: 
 
 
D.O.A:                                              D.O.S:                                      D.O.D: 
 
 
PRESENTING  COMPLAINTS: 
 
Hematuria                                        Dysuria                                     Frequency  of  Micturition                                
 
 
GENERAL EXAMINATION:                                    P.R:                B.P: 
 
 
PER ABDOMEN: 
 
 
INVESTIGATIONS: 
 
HB%:                             PCV% 
 
  
BLOOD: UREA-                                                   SUGAR 
 
SERUM CREATININE-                                       ELECTROLYTES 
 
URINE  C/S: 
 
URINE  CYTOLOGY 
 
           POSITIVE                          NEGATIVE                       SUSPCIOUS           ATYPIA 
 
USG KUB: 
 
     GROWTH          
 
                       HYPERECHOIC                                               HYPOECHOIC 
 
                       MIXED ECHOIC                                              ISOECHOIC 
 
 
 
 
 
CYSTOSCOPY: 
 
TYPE OF LESION 
 
         PEDUNCULATED 
 
         SESSILE 
 
LOCATION  OF TUMOUR 
 
         LATERAL WALL 
 
        ANTERIOR WALL 
 
        POSTERIOR  WALL 
 
        BASE  & NECK  OF BLADDER 
 
NUMBER 
 
      SINGLE  
 
      MULTIPLE 
 
SIZE OF TUMOUR 
 
    <2cm                                                  2-5 cm                                         > 5cm 
 
 
POST OP  BIOPSY: 
 
HISTOLOGY 
 
TRANSITIONAL  CELL  CARCINOMA 
     
 
     GRADE  I                                                                              pTa 
 
     GRADE  II                                                                             pTis 
 
     GRADE  III                                                                            pT1 
 
                                                                                                     p T2  &  above 
 
     
IMPRESSION: 
ANNEXURE 3
  
 
 
MASTER CHART 
 
Positive
Suspicious
Atypical
Negative
Low grade
High grade
Negative
1
G
un
al
an
62
/M
21
97
H
D
F
P
*
H
Y
PO
LA
T
SE
S
S
2=
5
*
PT
2
TC
C
2
K
ris
hn
am
oo
rth
y
51
/M
34
35
H
D
P
*
M
IX
ED
PO
ST
SE
S
S
2=
5
*
PT
1
TC
C
3
M
al
lig
a
52
/F
34
28
H
F
*
H
Y
PO
LA
T
PE
D
M
>5
*
PT
is
TC
C
4
G
an
es
an
67
/M
34
55
H
D
F
P
*
H
Y
PO
B
A
SE
SE
S
M
2=
5
*
PT
2
TC
C
5
Ja
na
ki
63
/F
14
32
H
D
F
*
H
Y
PO
LA
T
SE
S
S
2=
5
*
PT
1
TC
C
6
N
el
so
n
52
/M
18
99
H
D
P
*
M
IX
ED
PO
ST
PE
D
S
<2
*
PT
2
TC
C
7
V
as
ud
ev
an
54
/M
14
37
7
H
D
F
P
*
H
Y
PO
D
O
M
E
SE
S
M
>5
*
PT
2
TC
C
8
R
av
i
66
/M
14
22
3
H
D
F
*
H
Y
PE
R
PO
ST
PE
D
S
2=
5
*
PT
is
TC
C
9
Su
nd
ar
an
55
/M
42
29
2
H
D
P
*
H
Y
PO
LA
T
SE
S
M
2=
5
*
PT
is
TC
C
10
Su
dh
ar
as
an
72
/M
14
19
H
D
F
P
*
H
Y
PO
B
A
SE
SE
S
S
2=
5
*
PT
1
TC
C
11
K
at
hi
re
sa
n
64
/M
11
98
6
D
F
P
*
M
IX
ED
LA
T
PE
D
M
<2
*
PT
2
TC
C
12
D
ha
na
am
m
al
56
/F
11
28
8
H
D
*
M
IX
ED
LA
T
PE
D
M
2=
5
*
Pt
a
TC
C
13
M
ah
an
at
ha
n
34
/M
11
33
1
H
D
F
P
*
H
Y
PO
LA
T
SE
S
S
2=
5
*
PT
a
TC
C
14
Sa
m
uv
el
47
/M
11
47
94
H
D
F
P
*
H
Y
PO
PO
ST
SE
S
M
2=
5
*
PT
is
TC
C
15
V
ee
ra
m
an
i
56
/M
23
72
H
D
F
*
IS
O
LA
T
PE
D
S
2=
5
*
PT
1
TC
C
16
Sh
an
th
i
53
/F
40
99
H
F
P
*
M
IX
ED
B
A
SE
PE
D
M
>5
*
PT
a
TC
C
17
K
ot
ha
nd
ar
am
an
57
/M
40
93
H
D
P
*
H
Y
PO
LA
T
SE
S
M
2=
5
*
PT
2
TC
C
18
A
ru
m
ug
am
69
/M
53
35
H
D
F
P
*
H
Y
PO
PO
ST
PE
D
S
2=
5
*
PT
is
TC
C
19
Sa
nk
ar
am
oo
rth
y
56
/M
60
45
H
F
P
*
H
Y
PO
A
N
T
PE
D
S
2=
5
*
PT
2
TC
C
20
A
ns
ar
 b
as
ha
59
/M
70
98
H
D
*
H
Y
PE
R
LA
T
PE
D
M
>5
*
PT
is
TC
C
21
Po
nn
us
am
y
52
/M
70
89
H
F
P
*
H
Y
PO
LA
T
PE
D
M
>5
*
PT
a
TC
C
22
Sh
an
m
ug
am
77
/M
10
77
H
D
F
P
*
M
IX
ED
B
A
SE
SE
S
S
2=
5
*
PT
1
TC
C
23
Ja
na
rth
an
66
/M
16
87
3
H
D
P
*
H
Y
PO
PO
ST
SE
S
S
2=
5
*
PT
2
A
D
EN
O
24
M
ur
ug
am
m
al
59
/F
20
35
1
H
D
F
P
*
H
Y
PO
LA
T
SE
S
M
>5
*
PT
is
TC
C
25
Lo
ga
na
th
an
56
/M
23
54
6
H
F
P
*
M
IX
ED
LA
T
PE
D
M
2=
5
*
PT
2
TC
C
26
V
ig
ne
sh
48
/M
21
81
H
D
F
P
*
H
Y
PO
LA
T
PE
D
S
2=
5
*
PT
is
TC
C
27
So
un
da
pp
an
49
/M
23
78
2
H
D
F
*
H
Y
PO
LA
T
SE
S
M
2=
5
*
PT
2
TC
C
28
B
ab
u
67
/M
23
76
D
F
P
*
H
Y
PO
PO
ST
SE
S
S
2=
5
*
PT
2
TC
C
29
Pa
rth
as
ar
th
y
51
/M
87
54
H
D
P
*
H
Y
PO
LA
T
PE
D
S
<2
*
PT
1
TC
C
30
Le
el
av
at
hy
51
/F
52
77
H
D
F
P
*
H
Y
PE
R
B
A
SE
SE
S
S
>5
*
PT
is
TC
C
31
Su
re
sh
56
/M
23
41
H
D
*
M
IX
ED
LA
T
SE
S
S
2=
5
*
PT
1
TC
C
32
N
ar
as
im
an
59
/M
52
73
H
D
F
P
*
H
Y
PO
PO
ST
SE
S
M
2=
5
*
PT
is
TC
C
33
Si
va
sa
m
y
68
/M
54
60
H
D
F
P
*
H
Y
PO
LA
T
PE
D
S
2=
5
*
PT
2
TC
C
34
Sr
in
iv
as
an
47
/M
25
87
H
D
P
*
H
Y
PO
LA
T
PE
D
M
2=
5
*
PT
a
TC
C
35
C
ha
na
dr
as
ek
ar
52
/M
30
98
H
F
*
IS
O
LA
T
SE
S
S
>5
*
PT
2
TC
C
36
Se
lv
i
56
/F
54
69
H
D
F
*
M
IX
ED
LA
T
PE
D
S
2=
5
*
PT
1
TC
C
M
A
ST
E
R
 C
H
A
R
T
Urine                     
cytology
Histologica
l diagnosis
S. NO
Name
Age/Sex
IP NO
Clinical Features
Smoking
Ultrasound  findings
Location of  lesions
Type of lesions
No of tumours
 Tumour Size 
Tumour  staging
Type of Tumour
37
R
ub
an
54
/M
70
45
H
D
F
P
*
H
Y
PO
LA
T
SE
S
M
<2
*
PT
is
TC
C
38
SU
B
R
A
M
A
N
I
69
/M
21
14
D
F
P
*
H
Y
PO
PO
ST
SE
S
S
2=
5
*
PT
2
TC
C
39
Se
lv
am
an
i
38
/M
12
32
H
D
F
P
*
M
IX
ED
LA
T
SE
S
M
2=
5
*
PT
is
TC
C
40
B
al
ak
ris
hn
an
73
/M
14
10
H
D
P
*
H
Y
PO
LA
T
SE
S
S
>5
*
PT
a
TC
C
41
D
ha
na
si
ng
h
55
/M
11
78
H
D
F
P
*
H
Y
PE
R
PO
ST
SE
S
M
2=
5
*
PT
2
TC
C
42
A
m
ee
n
59
/M
71
55
H
D
F
P
*
H
Y
PO
B
A
SE
PE
D
S
2=
5
*
PT
1
TC
C
43
G
an
es
an
45
/M
30
99
H
D
P
*
H
Y
PO
LA
T
PE
D
S
2=
5
*
PT
is
TC
C
44
R
aj
u
62
/M
31
28
H
F
P
*
H
Y
PO
LA
T
SE
S
S
>5
*
PT
2
TC
C
45
K
al
ia
m
m
al
64
/F
39
44
H
D
F
*
M
IX
ED
PO
ST
PE
D
M
2=
5
*
PT
2
TC
C
46
C
he
lla
du
ra
i
58
/M
40
62
H
D
F
P
*
H
Y
PO
LA
T
SE
S
S
<2
*
PT
is
TC
C
47
Se
lv
am
an
i
66
/M
40
64
H
D
P
*
M
IX
ED
D
O
M
E
SE
S
S
2=
5
*
PT
a
TC
C
48
N
ar
ay
an
an
54
/M
40
68
H
D
F
*
H
Y
PO
LA
T
PE
D
S
<2
*
PT
is
TC
C
49
Et
hi
r
72
/M
40
95
H
D
P
*
H
Y
PO
B
A
SE
SE
S
M
>5
*
PT
is
TC
C
50
C
he
lla
du
ra
i
44
/M
73
89
H
D
P
*
H
Y
PE
R
LA
T
PE
D
S
2=
5
*
PT
2
A
D
EN
O
51
V
el
us
am
y
67
/M
74
50
H
D
F
*
M
IX
ED
LA
T
PE
D
S
2=
5
*
PT
1
TC
C
52
A
ru
m
ug
am
53
/M
76
53
H
D
P
*
H
Y
PO
PO
ST
SE
S
S
2=
5
*
PT
a
TC
C
53
N
ar
as
im
an
71
/M
78
22
H
D
P
*
H
Y
PO
LA
T
SE
S
M
<2
*
PT
2
TC
C
54
Si
va
sa
m
y
42
/M
77
09
H
D
F
P
*
IS
O
LA
T
PE
D
S
>5
*
PT
is
TC
C
55
Po
rk
ai
pa
nd
ia
n
69
/M
11
98
6
H
D
*
H
Y
PO
A
N
T
SE
S
S
<2
*
PT
1
TC
C
56
Si
ng
ar
av
el
56
/M
11
28
8
H
D
P
*
M
IX
ED
PO
ST
SE
SS
M
2=
5
*
PT
2
TC
C
57
Ta
m
il 
se
lv
i
67
/F
11
33
1
H
D
F
P
*
H
Y
PO
B
A
SE
SE
S
S
2=
5
*
PT
2
TC
C
58
C
ha
na
dr
an
82
/M
11
47
9
D
F
P
*
H
Y
PO
LA
T
SE
S
S
2=
5
*
PT
a
TC
C
59
V
aj
ra
m
58
/M
12
37
4
H
D
*
H
Y
PO
D
O
M
E
SE
S
M
2=
5
*
PT
1
TC
C
60
Se
lv
am
an
i
61
/M
14
90
9
H
D
F
*
IS
O
PO
ST
PE
D
S
>5
*
PT
is
TC
C
61
K
ar
th
ik
a
42
/F
15
33
5
H
F
P
*
H
Y
PO
B
A
SE
SE
S
S
2=
5
*
PT
2
TC
C
62
Pe
ru
m
al
59
/M
15
08
3
H
D
F
P
*
H
Y
PO
LA
T
SE
S
M
>5
*
PT
1
TC
C
63
K
an
na
n
63
/M
17
09
8
H
D
P
*
M
IX
ED
LA
T
SE
S
S
2=
5
*
PT
2
TC
C
64
K
ar
up
ia
h
44
/M
16
78
8
H
D
F
P
*
H
Y
PO
PO
ST
SE
S
S
2=
5
*
PT
a
TC
C
65
M
ad
hu
57
/F
22
78
3
H
D
P
*
H
Y
PE
R
LA
T
SE
S
M
>5
*
PT
2
TC
C
66
R
an
ga
sa
m
y
69
/M
22
78
2
H
D
F
P
*
H
Y
PO
B
A
SE
PE
D
S
2=
5
*
PT
is
TC
C
67
V
ee
ra
n
54
/M
20
36
5
H
D
F
P
*
H
Y
PO
A
N
T
SE
S
M
<2
*
PT
1
TC
C
68
M
ee
ra
n
42
/M
22
78
2
H
D
*
M
IX
ED
PO
ST
SE
S
M
2=
5
*
PT
is
TC
C
69
G
ov
in
da
sa
m
y
55
/M
76
54
2
H
D
F
P
*
H
Y
PO
LA
T
SE
S
S
>5
*
PT
2
TC
C
70
G
ee
th
a
45
/F
45
67
7
H
D
F
P
*
H
Y
PO
LA
T
SE
S
S
2=
5
*
PT
is
TC
C
  
 
A
N
N
EX
U
R
E
 -4
 
 
